
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="D0BD41E4AC192A450000239B61AC1672.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="ncomms" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC11150406/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11150406/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Nature Communications" /><meta name="citation_title" content="Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis" /><meta name="citation_author" content="Yu-Lan Ma" /><meta name="citation_author_institution" content="Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China" /><meta name="citation_author_institution" content="Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China" /><meta name="citation_author" content="Chun-Yan Kong" /><meta name="citation_author_institution" content="Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China" /><meta name="citation_author_institution" content="Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China" /><meta name="citation_author" content="Zhen Guo" /><meta name="citation_author_institution" content="Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China" /><meta name="citation_author_institution" content="Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China" /><meta name="citation_author" content="Ming-Yu Wang" /><meta name="citation_author_institution" content="Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China" /><meta name="citation_author_institution" content="Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China" /><meta name="citation_author" content="Pan Wang" /><meta name="citation_author_institution" content="Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China" /><meta name="citation_author_institution" content="Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China" /><meta name="citation_author" content="Fang-Yuan Liu" /><meta name="citation_author_institution" content="Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China" /><meta name="citation_author_institution" content="Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China" /><meta name="citation_author" content="Dan Yang" /><meta name="citation_author_institution" content="Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China" /><meta name="citation_author_institution" content="Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China" /><meta name="citation_author" content="Zheng Yang" /><meta name="citation_author_institution" content="Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China" /><meta name="citation_author_institution" content="Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China" /><meta name="citation_author" content="Qi-Zhu Tang" /><meta name="citation_author_institution" content="Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China" /><meta name="citation_author_institution" content="Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China" /><meta name="citation_publication_date" content="2024" /><meta name="citation_volume" content="15" /><meta name="citation_doi" content="10.1038/s41467-024-48970-2" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC11150406/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC11150406/" /><meta name="citation_pmid" content="38834564" /><meta name="DC.Title" content="Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Yu-Lan Ma" /><meta name="DC.Contributor" content="Chun-Yan Kong" /><meta name="DC.Contributor" content="Zhen Guo" /><meta name="DC.Contributor" content="Ming-Yu Wang" /><meta name="DC.Contributor" content="Pan Wang" /><meta name="DC.Contributor" content="Fang-Yuan Liu" /><meta name="DC.Contributor" content="Dan Yang" /><meta name="DC.Contributor" content="Zheng Yang" /><meta name="DC.Contributor" content="Qi-Zhu Tang" /><meta name="DC.Date" content="2024" /><meta name="DC.Identifier" content="10.1038/s41467-024-48970-2" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis" /><meta property="og:type" content="article" /><meta property="og:description" content="Semaglutide, a glucagon-like peptide-1 receptor agonist, is clinically used as a glucose-lowering and weight loss medication due to its effects on energy metabolism. In heart failure, energy production is impaired due to altered mitochondrial function ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11150406/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11150406/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Nat%20Commun%22[journal]" class="navlink">Nat Commun</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC11150406
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC11150406/pdf/41467_2024_Article_48970.pdf" class="int-view">PDF (6.5M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/11150406/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/11150406/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="11150406" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11150406%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="M4TK2vqjEv1YS8OAu1kItg679pwNlI5Q08w5RoG45ncK4YNu9nMLb2SYT43pWEDV">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11150406%2F&amp;text=Semaglutide%20ameliorates%20cardiac%20remodeling%20in%20male%20mice%20by%20optimizing%20energy%20substrate%20utilization%20through%20the%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11150406%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11150406/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC11150406/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/38834564/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC11150406/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/38834564/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC11150406/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/11150406/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Nat%20Commun%22[journal]" class="navlink">Nat Commun</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC11150406
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-ncomms.gif" alt="Logo of ncomms" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://www.nature.com/ncomms/index.html" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Nat Commun.</span> 2024; 15: 4757. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2024 Jun 4. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1038%2Fs41467-024-48970-2" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1038/s41467-024-48970-2</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC11150406</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38834564">38834564</a></div></div></div><h1 class="content-title">Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ma%20YL%5BAuthor%5D" class="affpopup" co-rid="_co_idm140003593687968" co-class="co-affbox">Yu-Lan Ma</a>,<sup>#</sup><sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kong%20CY%5BAuthor%5D" class="affpopup" co-rid="_co_idm140003547910304" co-class="co-affbox">Chun-Yan Kong</a>,<sup>#</sup><sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Guo%20Z%5BAuthor%5D" class="affpopup" co-rid="_co_idm140003547908016" co-class="co-affbox">Zhen Guo</a>,<sup>#</sup><sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wang%20MY%5BAuthor%5D" class="affpopup" co-rid="_co_idm140003552340208" co-class="co-affbox">Ming-Yu Wang</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wang%20P%5BAuthor%5D" class="affpopup" co-rid="_co_idm140003592804832" co-class="co-affbox">Pan Wang</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liu%20FY%5BAuthor%5D" class="affpopup" co-rid="_co_idm140003592802112" co-class="co-affbox">Fang-Yuan Liu</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yang%20D%5BAuthor%5D" class="affpopup" co-rid="_co_idm140003537513856" co-class="co-affbox">Dan Yang</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yang%20Z%5BAuthor%5D" class="affpopup" co-rid="_co_idm140003547799056" co-class="co-affbox">Zheng Yang</a>,<sup>1,</sup><sup>2</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Tang%20QZ%5BAuthor%5D" class="affpopup" co-rid="_co_idm140003547796336" co-class="co-affbox">Qi-Zhu Tang</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1,</sup><sup>2</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140003593687968"><h3 class="no_margin">Yu-Lan Ma</h3><p><sup>1</sup>Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China </p><p><sup>2</sup>Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ma%20YL%5BAuthor%5D">Yu-Lan Ma</a></div></div><div id="_co_idm140003547910304"><h3 class="no_margin">Chun-Yan Kong</h3><p><sup>1</sup>Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China </p><p><sup>2</sup>Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kong%20CY%5BAuthor%5D">Chun-Yan Kong</a></div></div><div id="_co_idm140003547908016"><h3 class="no_margin">Zhen Guo</h3><p><sup>1</sup>Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China </p><p><sup>2</sup>Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Guo%20Z%5BAuthor%5D">Zhen Guo</a></div></div><div id="_co_idm140003552340208"><h3 class="no_margin">Ming-Yu Wang</h3><p><sup>1</sup>Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China </p><p><sup>2</sup>Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wang%20MY%5BAuthor%5D">Ming-Yu Wang</a></div></div><div id="_co_idm140003592804832"><h3 class="no_margin">Pan Wang</h3><p><sup>1</sup>Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China </p><p><sup>2</sup>Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wang%20P%5BAuthor%5D">Pan Wang</a></div></div><div id="_co_idm140003592802112"><h3 class="no_margin">Fang-Yuan Liu</h3><p><sup>1</sup>Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China </p><p><sup>2</sup>Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liu%20FY%5BAuthor%5D">Fang-Yuan Liu</a></div></div><div id="_co_idm140003537513856"><h3 class="no_margin">Dan Yang</h3><p><sup>1</sup>Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China </p><p><sup>2</sup>Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yang%20D%5BAuthor%5D">Dan Yang</a></div></div><div id="_co_idm140003547799056"><h3 class="no_margin">Zheng Yang</h3><p><sup>1</sup>Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China </p><p><sup>2</sup>Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yang%20Z%5BAuthor%5D">Zheng Yang</a></div></div><div id="_co_idm140003547796336"><h3 class="no_margin">Qi-Zhu Tang</h3><p><sup>1</sup>Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China </p><p><sup>2</sup>Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Tang%20QZ%5BAuthor%5D">Qi-Zhu Tang</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140003593915840_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140003593915840_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140003593915840_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140003593915840_ai" style="display:none"><div class="fm-affl" id="Aff1"><sup>1</sup>Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060 PR China </div><div class="fm-affl" id="Aff2"><sup>2</sup>Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, 430060 PR China </div><div><span class="fm-affl">Qi-Zhu Tang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.ude.uhw@gnatzq" class="oemail">nc.ude.uhw@gnatzq</a></span>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div><sup>#</sup>Contributed equally.</div></div><div class="fm-article-notes hide half_rhythm" id="idm140003593915840_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2024 Jan 10; Accepted 2024 May 15.</div></div><div class="permissions half_rhythm hide" id="idm140003593915840_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; The Author(s) 2024</div><div class="license half_rhythm"><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/4.0/</a>.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="8" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Information</div><div><a href="/pmc/articles/PMC11150406/bin/41467_2024_48970_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl">41467_2024_48970_MOESM1_ESM.pdf</a><span style="color:gray"> (1.4M)</span></div><div class="small guid">GUID: 00800D31-7C57-46BE-9253-F47C394742E0</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Peer Review File</div><div><a href="/pmc/articles/PMC11150406/bin/41467_2024_48970_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl">41467_2024_48970_MOESM2_ESM.pdf</a><span style="color:gray"> (4.7M)</span></div><div class="small guid">GUID: 2C3EBF14-8937-44E6-A7C5-4F8EBCDB0423</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Description of Additional Supplementary Files</div><div><a href="/pmc/articles/PMC11150406/bin/41467_2024_48970_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl">41467_2024_48970_MOESM3_ESM.pdf</a><span style="color:gray"> (31K)</span></div><div class="small guid">GUID: D3B447E5-2C4B-4609-A124-3DC3CDB1FEE8</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Dataset1</div><div><a href="/pmc/articles/PMC11150406/bin/41467_2024_48970_MOESM4_ESM.xlsx" data-ga-action="click_feat_suppl">41467_2024_48970_MOESM4_ESM.xlsx</a><span style="color:gray"> (357K)</span></div><div class="small guid">GUID: 8E41866A-B22F-4F30-A37E-6A13ED4535F3</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Dataset2</div><div><a href="/pmc/articles/PMC11150406/bin/41467_2024_48970_MOESM5_ESM.xlsx" data-ga-action="click_feat_suppl">41467_2024_48970_MOESM5_ESM.xlsx</a><span style="color:gray"> (12K)</span></div><div class="small guid">GUID: 93F4F959-8BE3-474F-9552-D4CFA3EBDFB3</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Dataset 3</div><div><a href="/pmc/articles/PMC11150406/bin/41467_2024_48970_MOESM6_ESM.xlsx" data-ga-action="click_feat_suppl">41467_2024_48970_MOESM6_ESM.xlsx</a><span style="color:gray"> (1.0M)</span></div><div class="small guid">GUID: D82146B2-EA66-44B8-B751-5F9C87B92707</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Reporting Summary</div><div><a href="/pmc/articles/PMC11150406/bin/41467_2024_48970_MOESM7_ESM.pdf" data-ga-action="click_feat_suppl">41467_2024_48970_MOESM7_ESM.pdf</a><span style="color:gray"> (110K)</span></div><div class="small guid">GUID: 71D065A5-4B49-441A-8C65-4F8A3A9C07F6</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">source data</div><div><a href="/pmc/articles/PMC11150406/bin/41467_2024_48970_MOESM8_ESM.xlsx" data-ga-action="click_feat_suppl">41467_2024_48970_MOESM8_ESM.xlsx</a><span style="color:gray"> (666K)</span></div><div class="small guid">GUID: CA3D2095-5FB5-4447-B288-2E23DAD518F7</div></div></dd></dl><dl data-length="617" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p>The data supporting the findings from this study are available within the manuscript and its&#x000a0;<sup><a href="#MOESM1" rid="MOESM1" class=" media">supplementary information</a></sup>. Source data are provided with this paper. Any additional raw data are available from the corresponding author upon reasonable request. The datasets generated for the RNA-seq are available through the Gene Expression Omnibus under accession code <a class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE262105" ref="/geo/query/acc.cgi?acc=GSE262105"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE262105","term_id":"262105"}}</span>GSE262105</a>. The Metabolomic data generated in this study have been deposited in MassIVE under accession code ID: <a href="ftp://massive.ucsd.edu/v07/MSV000094408/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">MSV000094408</a>.&#x000a0;<a href="#Sec30" rid="Sec30" class=" sec">Source data</a> are provided with this paper.</p></dd></dl></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><p id="Par1" class="p p-first-last">Semaglutide, a glucagon-like peptide-1 receptor agonist, is clinically used as a glucose-lowering and weight loss medication due to its effects on energy metabolism. In heart failure, energy production is impaired due to altered mitochondrial function and increased glycolysis. However, the impact of semaglutide on cardiomyocyte metabolism under pressure overload remains unclear. Here we demonstrate that semaglutide improves cardiac function and reduces hypertrophy and fibrosis in a mouse model of pressure overload-induced heart failure. Semaglutide preserves mitochondrial structure and function under chronic stress. Metabolomics reveals that semaglutide reduces mitochondrial damage, lipid accumulation, and ATP deficiency by promoting pyruvate entry into the tricarboxylic acid cycle and increasing fatty acid oxidation. Transcriptional analysis shows that semaglutide regulates myocardial energy metabolism through the Creb5/NR4a1 axis in the PI3K/AKT pathway, reducing NR4a1 expression and its translocation to mitochondria. NR4a1 knockdown ameliorates mitochondrial dysfunction and abnormal glucose and lipid metabolism in the heart. These findings suggest that semaglutide may be a therapeutic agent for improving cardiac remodeling by modulating energy metabolism.</p></div><div class="sec"><strong class="kwd-title">Subject terms: </strong><span class="kwd-text">Cardiac hypertrophy, Heart failure, Metabolism</span></div></div><div id="Abs2" lang="en" class="tsec sec"><h2 class="headless nomenu"></h2><!--article-meta--><div><p id="Par2" class="p p-first-last">Semaglutide is used for glucose control and weight reduction. Here, the authors show that it enhances myocardial metabolism by targeting Creb5/NR4a1, protecting against cardiac remodeling and offering a therapeutic approach for heart failure through metabolic regulation.</p></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Introduction</h2><p id="Par3" class="p p-first">Chronic stress, encompassing conditions such as hypertension, is widely recognized for leading to adverse cardiac remodeling and subsequent heart failure (HF), a condition with high rates of mortality and morbidity<sup><sup><a href="#CR1" rid="CR1" class=" bibr popnode">1</a></sup></sup>. Energy metabolic flexibility enables a healthy heart to adapt its utilization of metabolic substrates in response to fluctuations in circulating substrate concentrations and oxygen availability, ensuring sustained ATP production<sup><sup><a href="#CR2" rid="CR2" class=" bibr popnode">2</a></sup></sup>. Unfortunately, the heart loses metabolic flexibility and undergoes myocardial metabolic remodeling at the onset of HF. While cardiac energy is generated primarily by mitochondrial oxidative phosphorylation, glycolysis contributes approximately 5% to the total energy production<sup><sup><a href="#CR3" rid="CR3" class=" bibr popnode">3</a></sup></sup>. In healthy individuals, the heart derives approximately 60-90% of its energy from fatty acid oxidation<sup><sup><a href="#CR2" rid="CR2" class=" bibr popnode">2</a></sup></sup>. In HF, the inadequate supply of oxygen causes the heart to take up and utilize glucose as a more efficient energy&#x000a0;substrate<sup><sup><a href="#CR4" rid="CR4" class=" bibr popnode">4</a></sup></sup>. However, defects in mitochondrial structure and function lead to increased glucose uptake but incomplete oxidation, thereby inducing glycolysis<sup><sup><a href="#CR5" rid="CR5" class=" bibr popnode">5</a></sup></sup>. Additionally, the transport and metabolism of pyruvate into the tricarboxylic acid (TCA) cycle are reduced in cases of HF<sup><sup><a href="#CR6" rid="CR6" class=" bibr popnode">6</a></sup>,<sup><a href="#CR7" rid="CR7" class=" bibr popnode">7</a></sup></sup>. Studies have shown that cardiac energy metabolism in HF patients switches from fatty acid oxidation to glycolysis over glucose oxidation, resulting in diminished ATP generating capacity and inadequate cardiac energy supply<sup><sup><a href="#CR8" rid="CR8" class=" bibr popnode">8</a></sup>,<sup><a href="#CR9" rid="CR9" class=" bibr popnode">9</a></sup></sup>. Thus, addressing the inadequate myocardial energy supply, primarily through mitigating mitochondrial deficits, is crucial for HF management.</p><p id="Par4">Preclinical studies have demonstrated that compounds promoting glucose oxidation, such as dichloroacetate (DCA), can inhibit pyruvate dehydrogenase complex (PDC) kinase. This inhibition stimulates PDC activity, enhancing glucose oxidation and mitochondrial respiration, and subsequently mitigates cardiac hypertrophy in HF models using animals<sup><sup><a href="#CR10" rid="CR10" class=" bibr popnode">10</a></sup></sup>. Unfortunately, the toxic effects of DCA have limited its clinical use and further development<sup><sup><a href="#CR11" rid="CR11" class=" bibr popnode">11</a></sup></sup>. Another compound, elamipretide, appears to influence metabolism by augmenting mitochondrial function; however, preclinical evidence indicates it fails to enhance cardiac function in HF scenarios<sup><sup><a href="#CR12" rid="CR12" class=" bibr popnode">12</a></sup></sup>. Consequently, identifying drugs that boost mitochondrial function and glucose oxidation to address the energy deficiency in HF represents a significant challenge<sup><sup><a href="#CR13" rid="CR13" class=" bibr popnode">13</a></sup></sup>. Semaglutide (Sema), in contrast, has exhibited cardiovascular advantages in clinical trials, notably among HF patients with obesity and preserved ejection fraction<sup><sup><a href="#CR14" rid="CR14" class=" bibr popnode">14</a></sup></sup>. Nevertheless, research into Sema&#x02019;s mechanistic effects on HF remains scant. Our study seeks to bridge this knowledge gap by exploring the detailed metabolic mechanisms underlying Sema&#x02019;s cardiovascular benefits.</p><p id="Par5">Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used clinically as blood glucose-lowering agents in the treatment of type 2 diabetes mellitus&#x000a0;(T2DM), and these drugs also have a weight-lowering effect<sup><sup><a href="#CR15" rid="CR15" class=" bibr popnode">15</a></sup></sup>. Recently approved by the US Food and Drug Administration (FDA) as the first oral GLP-1RA for treating T2DM, Sema has demonstrated cardiovascular benefits in clinical trials involving patients with T2DM<sup><sup><a href="#CR16" rid="CR16" class=" bibr popnode">16</a></sup></sup>. With its pronounced effect on weight loss, Sema has predominantly been adopted in clinical practice as a therapeutic agent for weight management<sup><sup><a href="#CR17" rid="CR17" class=" bibr popnode">17</a></sup></sup>. In addition, Sema has been confirmed to have an ameliorative effect on disturbed lipid and glucose metabolism in obesity syndrome and T2DM<sup><sup><a href="#CR18" rid="CR18" class=" bibr popnode">18</a></sup>,<sup><a href="#CR19" rid="CR19" class=" bibr popnode">19</a></sup></sup>. In particular, Sema has recently been shown to have a significant improvement in&#x000a0;HF with preserved ejection fraction (HFpEF) and obesity<sup><sup><a href="#CR14" rid="CR14" class=" bibr popnode">14</a></sup></sup>. Despite these promising outcomes, the specific mechanisms driving Sema&#x02019;s cardiac benefits remain to be elucidated. Consequently, our study aims to explore Sema&#x02019;s impact on cardiac remodeling, aiming to underscore its therapeutic potential in addressing pathological cardiac remodeling and HF.</p><p id="Par6" class="p p-last">Our study revealed that Sema treatment effectively suppressed pressure overload-induced pathological hypertrophy and cardiac dysfunction in&#x000a0;male mice, a condition accompanied by significant mitochondrial damage in chronic HF induced by transverse aortic constriction (TAC). This damage was characterized by a reduction in mitochondrial count, alongside mitochondrial swelling, fragmentation, and deterioration of the inner mitochondrial membrane and cristae. The metabolic profile of these mice shifted towards an increase in glycolysis and a significant decrease in fatty acid oxidative phosphorylation. Treatment with Sema reduced mitochondrial functional and structural abnormalities. Correspondingly, Sema promoted the entry of pyruvate into mitochondria, facilitated the complete oxidation of glucose, and increased the oxidation capacity of fatty acids to some extent. NR4a1 is a member of the nuclear receptor superfamily, which plays an important role in the control of metabolism, autophagy, inflammation, and mitochondrial biogenesis<sup><sup><a href="#CR20" rid="CR20" class=" bibr popnode">20</a></sup>&#x02013;<sup><a href="#CR22" rid="CR22" class=" bibr popnode">22</a></sup></sup>. Transcriptome analysis disclosed that NR4a1 mitochondrial translocation is a major target in the regulation of glucose and lipid metabolism by Sema. NR4a1 plays a role in the regulation of mitochondria-dependent apoptosis<sup><sup><a href="#CR23" rid="CR23" class=" bibr popnode">23</a></sup></sup>. Our findings suggest that NR4a1 expression and translocation after TAC are crucial factors in mitochondrial dysfunction, resulting in metabolic remodeling and structural remodeling of the heart. These findings highlight the significant role of Sema in regulating glycolipid metabolism to mitigate cardiac remodeling. In particular, we revealed the regulatory mechanism of the Sema critical regulator NR4a1.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Results</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Sema ameliorates myocardial hypertrophy and cardiac dysfunction induced by TAC for eight weeks in mice</h3><p id="Par7" class="p p-first-last">To investigate the effect of Sema on pathological cardiac remodeling, after TAC or sham surgery, we administered different doses (4&#x02009;&#x003bc;g/kg, 12&#x02009;&#x003bc;g/kg, and 60&#x02009;&#x003bc;g/kg) of Sema or vehicle to mice every day for eight weeks (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S1A</a></sup>). We found no significant effect of different doses of Sema on blood glucose, cholesterol or liver functions in mice (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S1D&#x02013;G</a></sup>). Sema is mainly used as a weight loss drug in clinical practice<sup><sup><a href="#CR24" rid="CR24" class=" bibr popnode">24</a></sup></sup>. Therefore, we chose the high dose (60&#x02009;&#x003bc;g/kg) with the most pronounced effect on body weight as the subsequent experimental dose (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S1B&#x02013;C</a></sup>). Our results showed that mice with TAC-induced cardiac dysfunction at eight weeks were significantly improved after Sema treatment, as evidenced by an elevated EF, FS, and a decreased LVIDd and LVIDs (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1A&#x02013;D</span></a>). In addition, hemodynamics significantly&#x000a0;improved after Sema treatment, as shown by &#x000b1;dp/dt, P-V loop indicators (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1E, F</span></a>). TAC-induced chronic stress resulted in substantial increases in myocardial hypertrophy (ANP and BNP mRNA levels) and cardiomyocyte cross-sectional area (CSA); in addition, the heart weight to body weight ratio (HW/BW), the lung weight to body weight ratio (LW/BW) and heart weight to tibial length ratio (HW/TL) levels were significantly increased. In contrast, TAC-induced myocardial hypertrophy was significantly attenuated after the administration of Sema (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1G&#x02013;J</span></a>). These results suggest that Sema can ameliorate the pathological ventricular hypertrophy and dysfunction induced by TAC.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC11150406/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140003544432816"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11150406_41467_2024_48970_Fig1_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 41467_2024_48970_Fig1_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11150406/bin/41467_2024_48970_Fig1_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140003544432816"><a target="object" rel="noopener" href="/pmc/articles/PMC11150406/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC11150406/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Fig. 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Sema attenuates cardiac hypertrophy, fibrosis and cardiac dysfunction in mice that underwent TAC for eight weeks.</strong><p><strong>A</strong> Representative B- and M-mode echocardiographic imaging of the heart. <strong>B</strong>&#x02013;<strong>D</strong> EF, FS, LVIDd and LVIDs were assessed by echocardiography (<em>n</em>&#x02009;=&#x02009;12); EF: F (3, 44)&#x02009;=&#x02009;54.15, <em>P</em>&#x02009;=&#x02009;8.2e-015; FS: F (3, 44)&#x02009;=&#x02009;101.2, <em>P</em>&#x02009;=&#x02009;9.1e-020; LVIDd: F (3, 44)&#x02009;=&#x02009;15.91, <em>P</em>&#x02009;=&#x02009;3.8e-007; LVIDs: F (3, 44)&#x02009;=&#x02009;90.69, <em>P</em>&#x02009;=&#x02009;7.2e-019. <strong>E</strong> The maximum rate of isovolumetric systolic LV pressure increase (&#x02009;+&#x02009;dp/dt max) and the minimum rate of isovolumetric diastolic LV pressure decrease (-dp/dt min) (<em>n</em>&#x02009;=&#x02009;12); +dp/dt max: F (3, 44)&#x02009;=&#x02009;52.79, <em>P</em>&#x02009;=&#x02009;1.3e-014; -dp/dt min: F (3, 44)&#x02009;=&#x02009;88.28, <em>P</em>&#x02009;=&#x02009;1.2e-018. <strong>F</strong> The ventricular pressure-volume loop (P-V loop) (<em>n</em>&#x02009;=&#x02009;6). <strong>G</strong> The ratio of LW, BW, HW, and TL (<em>n</em>&#x02009;=&#x02009;12); HW/TL: F (3, 44)&#x02009;=&#x02009;83.11, <em>P</em>&#x02009;=&#x02009;3.7e-018; HW/BW: F (3, 44)&#x02009;=&#x02009;47.17, <em>P</em>&#x02009;=&#x02009;8.5e-014; LW/BW: F (3, 44)&#x02009;=&#x02009;11.35, <em>P</em>&#x02009;=&#x02009;1.2e-005. <strong>H</strong>, <strong>I</strong> The mRNA expression of ANP, BNP, collagen I and collagen III in the heart (<em>n</em>&#x02009;=&#x02009;6); ANP: F (3, 20)&#x02009;=&#x02009;336.5, <em>P</em>&#x02009;=&#x02009;2.8e-017; BNP: F (3, 20)&#x02009;=&#x02009;276.1, <em>P</em>&#x02009;=&#x02009;1.9e-016; LW/BW: COL 1: F (3, 20)&#x02009;=&#x02009;210.4, <em>P</em>&#x02009;=&#x02009;2.7e-015; COL3: F (3, 20)&#x02009;=&#x02009;495.5, <em>P</em>&#x02009;=&#x02009;6.3e-019. <strong>J</strong> Myocardial hypertrophy was detected by WGA staining and then quantitatively analyzed (scale bar: 50 &#x003bc;m; <em>n</em>&#x02009;=&#x02009;6); CSA: F (3, 20)&#x02009;=&#x02009;36.38, <em>P</em>&#x02009;=&#x02009;2.7e-008. All results are shown as the mean&#x02009;&#x000b1;&#x02009;SEM and analyzed by one-way ANOVA followed by Bonferroni post hoc test (<strong>B</strong>&#x02013;<strong>E</strong> and <strong>G</strong>&#x02013;<strong>J</strong>). p values are indicated. Source data are provided as a Source Data file. EF, ejection fractions; FS, fractional shortening; LVIDd, left ventricular internal dimension at end-diastole; LVIDs, left ventricular internal dimension at end-systole; LW, lung weight; HW, heart weight; TL, tibial length; BW, body weight; BNP, B-type natriuretic peptide; ANP, A-type natriuretic peptide; WGA, wheat germ agglutinin.</p></div></div></div></div><div id="Sec4" class="sec"><h3 id="Sec4title">Sema reverses pathological myocardial remodeling induced by TAC</h3><p id="Par8" class="p p-first-last">Clinically, many patients come for treatment only when they already have altered cardiac function. Thus, we next further verified whether Sema reversed pathological myocardial remodeling by administering Sema treatment after four weeks after TAC (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2A</span></a>). We found that cardiac dysfunction was reversed in mice treated with Sema compared to that before the administration of the drug, as shown by the B- and M-mode echocardiograms, and elevated EF and FS (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2B&#x02013;D</span></a>). Moreover, WGA and HE staining revealed that the CSA of cardiomyocytes from Sema treatment mice was smaller than mice in control group (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2E&#x02013;G</span></a>). Likewise, Sema treatment mitigated collagen deposition (PSR staining), as assessed by reduced collagen volume in hearts (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2H, I</span></a>). In addition, the heart weight to body weight (HW/BW) and heart weight to tibial length (HW/TL) ratio were significantly reduced after Sema administration (Fig. <a href="/pmc/articles/PMC11150406/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2J).</span></span><span>2J</span></a>). Meanwhile, the mRNA levels of ANP, BNP, COL I, and COL III also indicated that Sema significantly attenuated TAC-induced myocardial hypertrophy and fibrosis (Fig. <a href="/pmc/articles/PMC11150406/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2K).&#x000a0;Parallel</span></span><span>2K</span></a>).&#x000a0;Parallel transcriptomic analysis of myocardial tissue from mice in the reversal experiment revealed that the treatment of Sema significantly rescued TAC-induced changes at the gene level (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S2A</a></sup>). The reversal experiment showed significant enrichment of DEGs in extracellular matrix (ECM), cell migration, and blood vessel development pathways (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S2B</a></sup>). It has been demonstrated that ECM plays an important role in pressure overload-induced heart failure, and excessive deposition of ECM proteins leads to fibrosis and deterioration of cardiac function<sup><sup><a href="#CR25" rid="CR25" class=" bibr popnode">25</a></sup></sup>. Similarly, cell migration is crucial for fibrosis, with myofibroblasts under pressure overload conditions in HF showing enhanced migration abilities, secreting ECM proteins, and leading to myocardial remodeling and stiffening, thereby impairing cardiac function<sup><sup><a href="#CR26" rid="CR26" class=" bibr popnode">26</a></sup></sup>. In addition, increased endothelial cell proliferation and promotion of angiogenesis significantly improve cardiac function in pressure overload-induced myocardial remodeling<sup><sup><a href="#CR27" rid="CR27" class=" bibr popnode">27</a></sup></sup>. Sema exerts anti-fibrotic and anti-hypertrophic effects by attenuating ECM proteins (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S2D</a></sup>), and, consistently, Sema application inhibits deterioration of cardiac function, development of cardiac fibrosis and cardiac hypertrophy in response to pressure overload (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2</span></a>). These results suggest that Sema can also reverse TAC-induced pathological myocardial remodeling.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC11150406/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140003536856432"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11150406_41467_2024_48970_Fig2_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 41467_2024_48970_Fig2_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11150406/bin/41467_2024_48970_Fig2_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140003536856432"><a target="object" rel="noopener" href="/pmc/articles/PMC11150406/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC11150406/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Fig. 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Sema reverses cardiac hypertrophy, fibrosis and dysfunction in mice that underwent TAC for eight weeks.</strong><p><strong>A</strong> The time of TAC and Sema&#x000a0;treatment (i.p.) in mice. <strong>B</strong> Representative B- and M-mode echocardiographic imaging of the heart. <strong>C</strong>, <strong>D</strong> Echocardiographic analysis of EF and FS in mice, data are presented as mean&#x02009;&#x000b1;&#x02009;SEM (<em>n</em>&#x02009;=&#x02009;6); EF: F (6, 88)&#x02009;=&#x02009;25.78, <em>P</em>&#x02009;=&#x02009;1.8e-017, F (1.947, 85.69)&#x02009;=&#x02009;75.90&#x02009;<em>P</em>&#x02009;=&#x02009;2.0e-019, F (3, 44)&#x02009;=&#x02009;124.5, <em>P</em>&#x02009;=&#x02009;1.6e-021, F (44, 88)&#x02009;=&#x02009;0.8118, <em>P</em>&#x02009;=&#x02009;7.8e-001, F (6, 132)&#x02009;=&#x02009;27.50, <em>P</em>&#x02009;=&#x02009;4.1e-021, F (2, 132)&#x02009;=&#x02009;80.98, <em>P</em>&#x02009;=&#x02009;1.1e-023, F (3, 132)&#x02009;=&#x02009;107.9, <em>P</em>&#x02009;=&#x02009;2.4e-035; FS: F (6, 132)&#x02009;=&#x02009;58.51, <em>P</em>&#x02009;=&#x02009;7.9e-035, F (2, 132)&#x02009;=&#x02009;144.4, <em>P</em>&#x02009;=&#x02009;5.9e-034, F (3, 132)&#x02009;=&#x02009;192.9, <em>P</em>&#x02009;=&#x02009;4.6e-048, F (6, 132)&#x02009;=&#x02009;58.51, <em>P</em>&#x02009;=&#x02009;7.9e-035, F (2, 132)&#x02009;=&#x02009;144.4, <em>P</em>&#x02009;=&#x02009;5.9e-034, F (3, 132)&#x02009;=&#x02009;192.9, <em>P</em>&#x02009;=&#x02009;4.6e-048. <strong>E</strong> Representative histopathological cross-sectional images of mice hearts (scale bar: 1&#x02009;mm; <em>n</em>&#x02009;=&#x02009;6). <strong>F</strong>, <strong>G</strong> Myocardial hypertrophy was detected by WGA staining and then quantitatively analyzed (scale bar: 50 &#x003bc;m; <em>n</em>&#x02009;=&#x02009;6); CSA: F (3, 20)&#x02009;=&#x02009;70.58, <em>P</em>&#x02009;=&#x02009;8.1e-011. <strong>H</strong>, <strong>I</strong> Myocardial fibrosis was detected by PSR staining and quantification of the collagen volume (scale bar: 50 &#x003bc;m; <em>n</em>&#x02009;=&#x02009;6); Fibrotic area: F (3, 20)&#x02009;=&#x02009;225.5, <em>P</em>&#x02009;=&#x02009;1.4e-015. <strong>J</strong> The ratio of BW, HW, and TL (<em>n</em>&#x02009;=&#x02009;12); HW/BW: F (3, 44)&#x02009;=&#x02009;180.2, <em>P</em>&#x02009;=&#x02009;1.0e-024; HW/TL: F (3, 44)&#x02009;=&#x02009;140.2, <em>P</em>&#x02009;=&#x02009;1.5e-022. <strong>K</strong> The mRNA expression levels of ANP, BNP, collagen I and collagen III in the heart (<em>n</em>&#x02009;=&#x02009;6); ANP and BNP:&#x000a0;F (7, 40)&#x02009;=&#x02009;138.8, <em>P</em>&#x02009;=&#x02009;5.2e-026; COLI and COL III: F (7, 40)&#x02009;=&#x02009;82.22, <em>P</em>&#x02009;=&#x02009;1.0e-021. All results are shown as the mean&#x02009;&#x000b1;&#x02009;SEM and analyzed using one-way ANOVA followed by Bonferroni post hoc test <strong>G</strong>, <strong>I</strong> and <strong>J</strong>, <strong>K</strong>. For the analysis in (<strong>C</strong>,<strong>D</strong>), repeated measures two-way ANOVA followed by Sidak post hoc test was conducted. p values are indicated. Source data are provided as a Source Data file. EF, ejection fractions; FS, fractional shortening; LW, lung weight; HW, heart weight; TL, tibial length; BW, body weight; BNP, B-type natriuretic peptide; ANP, A-type natriuretic peptide; WGA, wheat germ agglutinin; PSR, picrosirius red.</p></div></div></div></div><div id="Sec5" class="sec"><h3 id="Sec5title">Sema reduces TAC-induced mitochondrial fusion and division and maintains normal mitochondrial morphology and function</h3><p id="Par9" class="p p-first-last">Mitochondria are the energy centre of the heart, and dynamic mitochondrial division and fusion regulate fuel oxidative phosphorylation and the intracellular ATP supply in cardiomyocytes<sup><sup><a href="#CR28" rid="CR28" class=" bibr popnode">28</a></sup></sup>. Transcriptome GSEA showed that 234/1366 upregulated gene sets were significant at FDR&#x02009;&#x0003c;&#x02009;25% and enriched at nominal p value&#x02009;&#x0003c;&#x02009;1% in the TAC 8w with Sema group; of these gene sets, 92 were related to the metabolism of carbohydrates, energy, lipid nucleotides, amino acids, and mitochondrial function (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S3A, B</a></sup>; Supplementary Data&#x000a0;<sup><a href="#MOESM6" rid="MOESM6" class=" media">3</a></sup>). Thus, we hypothesized that Sema regulates the morphology and function of mitochondria in pathological myocardial remodeling. Mitochondrial respiratory chain proteins comprise five enzymatic complexes and guarantee the production of ATP<sup><sup><a href="#CR29" rid="CR29" class=" bibr popnode">29</a></sup></sup>. Transcriptome profiling showed the significant downregulation of most mitochondrial respiratory chain-related genes in hearts induced by TAC for eight weeks, whereas the hearts from the mice treated with Sema showed a reversed expression pattern (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3A</span></a>). Next, we performed transmission electron microscopy (TEM) and observed that the administration of Sema restored the swelling of the mitochondrial matrix and the shortening and reduction in cristae induced by TAC (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3B, C</span></a>). Additionally, the reduction abundance of mitochondria induced by TAC. After Sema treatment, mitochondrial numbers are restored (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3D</span></a>). Since mitochondrial fragmentation is mainly caused by mitochondrial fission and fusion imbalance or mitochondrial apoptosis<sup><sup><a href="#CR29" rid="CR29" class=" bibr popnode">29</a></sup></sup>, we further verified the protein and mRNA expression levels of mitochondrial fission (Drp1), fusion (Opa1 and Mfn2), apoptosis (Tom20 and COX IV) and mitochondrial respiration (SDHB, NDUFV2 and ATP5A1) markers by western blotting and PCR. The results showed that TAC induction led to increased mitochondrial fission and apoptosis and decreased fusion with impaired respiration, while Sema treatment ameliorated this imbalance and mitochondrial respiratory dysfunction (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3E, F</span></a>). These results suggest that Sema treatment can improve impaired mitochondrial respiration and mitochondrial structural disturbances in TAC-induced pathological myocardial remodeling.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC11150406/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140003545436608"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11150406_41467_2024_48970_Fig3_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 41467_2024_48970_Fig3_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11150406/bin/41467_2024_48970_Fig3_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140003545436608"><a target="object" rel="noopener" href="/pmc/articles/PMC11150406/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC11150406/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Fig. 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Sema restores mitochondrial dysfunction and morphology in pathological cardiac remodeling.</strong><p><strong>A</strong> Heatmap showing the expression profile of mitochondrial respiratory chain signaling pathway gene sets in mouse cardiac tissue (<em>n</em>&#x02009;=&#x02009;3). <strong>B</strong> TEM images of mouse cardiac tissues and quantification of the mitochondrial sectional area (scale bar: 2&#x003bc;m/1&#x003bc;m; <em>n</em>&#x02009;=&#x02009;6). <strong>C</strong> The quantification of fragmented fused mitochondria (<em>n</em>&#x02009;=&#x02009;6); Mitochondrial area: F (3, 20)&#x02009;=&#x02009;109.4, <em>P</em>&#x02009;=&#x02009;1.4e-012; Cristae/Mitochondrial area: F (3, 20)&#x02009;=&#x02009;84.57, <em>P</em>&#x02009;=&#x02009;1.6e-011. <strong>D</strong> The quantification of mitochondrial abundance by mitochondrial number and mtDNA/nDNA (<em>n</em>&#x02009;=&#x02009;6); Mitochondrial number; F (3, 20)&#x02009;=&#x02009;9.328, <em>P</em>&#x02009;=&#x02009;4.6e-004; MtDNA/nDNA: F (3, 20)&#x02009;=&#x02009;21.25, <em>P</em>&#x02009;=&#x02009;2.0e-006. <strong>E</strong> Western blotting was used for protein quantitative analysis of mitochondrial function- and structure-related marker proteins Drp1, Opa1, Mfn2, Tom20, COX IV, SDHB, NDUFV2, and ATP5A1 and normalized to VDAC (<em>n</em>&#x02009;=&#x02009;6 independent experiments with similar results); F (24, 160)&#x02009;=&#x02009;67.22, <em>P</em>&#x02009;=&#x02009;4.5e-071, F (3.243, 64.85)&#x02009;=&#x02009;126.4, <em>P</em>&#x02009;=&#x02009;8.4e-028, F (3, 20)&#x02009;=&#x02009;72.44, <em>P</em>&#x02009;=&#x02009;6.4e-011, F (20, 160)&#x02009;=&#x02009;0.9693, <em>P</em>&#x02009;=&#x02009;5.0e-001. <strong>F</strong> PCR was used for mRNA quantitative analysis of mitochondrial function- and structure-related marker proteins Drp1, Opa1, Mfn2, Tom20, COX IV, SDHB, NDUFV2 and ATP5A1 and normalized to VDAC (<em>n</em>&#x02009;=&#x02009;6); F (24, 160)&#x02009;=&#x02009;53.30, <em>P</em>&#x02009;=&#x02009;6.3e-064, F (4.911, 98.21)&#x02009;=&#x02009;49.04, <em>P</em>&#x02009;=&#x02009;5.4e-025, F (3, 20)&#x02009;=&#x02009;22.95, <em>P</em>&#x02009;=&#x02009;1.1e-006, F (20, 160)&#x02009;=&#x02009;1.417, <em>P</em>&#x02009;=&#x02009;1.2e-001. All results are shown as the mean&#x02009;&#x000b1;&#x02009;SEM, and analysis using one-way ANOVA followed by Bonferroni post hoc test (C-F) was conducted. p values are indicated. Source data are provided as a Source Data file. TEM, transmission electron microscopy; mtDNA, mitochondrial DNA; nDNA, nuclear DNA.</p></div></div></div></div><div id="Sec6" class="sec"><h3 id="Sec6title">Metabolome analysis shows that Sema ameliorates myocardial energy production by reducing glycolytic processes and lipid accumulation</h3><p id="Par10" class="p p-first-last">Based on the above results of the transcriptome sequencing (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S3A&#x02013;C</a></sup>), we next performed untargeted metabolomics analysis. We found that the mass spectrometry metabolomics and lipidomics results were consistent with the transcriptome sequencing results, as there were significant differences in lipid and metabolism-related total metabolites (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S4A&#x02013;D</a></sup>). The normal heart relies primarily on fatty acid oxidation for energy supply. In patients with pathological cardiac remodeling, cardiac lipid oxidation and the TCA cycle are inhibited, glycolysis is enhanced but glucose oxidation is unchanged or reduced, and the lack of energy supply further leads to HF<sup><sup><a href="#CR13" rid="CR13" class=" bibr popnode">13</a></sup>,<sup><a href="#CR30" rid="CR30" class=" bibr popnode">30</a></sup></sup>. Therefore, we refined the metabolites of glycolysis and the TCA-related pathways. We found that after eight weeks of TAC, the levels of cardiac glycolysis-related metabolites (glucose 6-P, fructose 6-P, 3-PG, PEP, and pyruvate), the pentose phosphate pathway (PPP) (glucose-1-P, 6-PG, and ribose-5-P) and lipids (stearic acid et al) were significantly increased, but the amount of pyruvate entering the TCA&#x000a0;cycle (citrate and aconitate) was reduced (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4A</span></a>). Despite the increased glucose utilization, the PPP increases and the&#x000a0;entry of&#x000a0;pyruvate into the TCA cycle is&#x000a0;decreased, which does not produce enough ATP for cardiac energy supply under TAC induction. The PPP is not used for myocardial energy supply but for nucleotide metabolism and fatty acid substrate production<sup><sup><a href="#CR7" rid="CR7" class=" bibr popnode">7</a></sup>,<sup><a href="#CR31" rid="CR31" class=" bibr popnode">31</a></sup></sup>. Surprisingly, our results show that administration of Sema reduces glycolysis levels and promotes pyruvate into the TCA&#x000a0;cycle, thereby increasing ATP production (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4A</span></a>). We further investigated lipid metabolism in TAC-induced pathological myocardial remodeling. We found that the TAC-induced increase in free fatty acids led to myocardial lipid accumulation, while myocardial lipid accumulation was significantly decreased after Sema treatment (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4B</span></a>). In addition, the results of the in vitro NRVM assay with oil red O staining also confirmed that PE stimulation can also increase myocardial lipid accumulation (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4C</span></a>). We next examined the mRNA levels of glycolytic key rate-limiting enzymes (HK2), TCA rate-limiting enzymes (IDH2 and PDH), lipid uptake and transport-related enzymes (CD36 and Slc27a1) and fatty acid &#x003b2;-oxidation (PDK4, ACOX1 and ACOT1) (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4D, E</span></a>) and found that all were consistent with the metabolic results (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4A, B</span></a>). Additionally, the same results were obtained for the western blot levels of glucose transporters (GLUT1 and GLUT4) and fatty acid transporters (CD36) (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4F, G</span></a>). In conclusion, Sema treatment reduced glycolysis and promoted its substrates into the TCA cycle to increase myocardial energy supply and reduce the lipid accumulation of TAC-induced pathological myocardial remodeling.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig4" co-legend-rid="lgnd_Fig4"><a href="/pmc/articles/PMC11150406/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140003554286112"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11150406_41467_2024_48970_Fig4_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 41467_2024_48970_Fig4_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11150406/bin/41467_2024_48970_Fig4_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140003554286112"><a target="object" rel="noopener" href="/pmc/articles/PMC11150406/figure/Fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig4"><div><a class="figpopup" href="/pmc/articles/PMC11150406/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4">Fig. 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Sema can improve myocardial energy production by reducing glycolytic processes and lipid accumulation.</strong><p><strong>A</strong> Untargeted metabolomics mass spectrometry-based pathway analysis of Sema therapeutic cardiometabolic characteristics, quantification of changes in glycolysis and the TCA products (the red/green boxes represent products that have changed significantly; <em>n</em>&#x02009;=&#x02009;6); Glucose 6-P: F (2, 15)&#x02009;=&#x02009;38.02, <em>P</em>&#x02009;=&#x02009;1.3e-006; Fructose 6-P: F (2, 15)&#x02009;=&#x02009;23.04, <em>P</em>&#x02009;=&#x02009;2.7e-005;3-PG: F (2, 15)&#x02009;=&#x02009;23.58, <em>P</em>&#x02009;=&#x02009;2.3e-005; PEP: F (2, 15)&#x02009;=&#x02009;58.41, <em>P</em>&#x02009;=&#x02009;8.3e-008; Pyruvate: F (2, 15)&#x02009;=&#x02009;72.71, <em>P</em>&#x02009;=&#x02009;1.9e-008; Glucose 1-P: F (2, 15)&#x02009;=&#x02009;24.41, <em>P</em>&#x02009;=&#x02009;1.9e-005; 6-PG: F (2, 15)&#x02009;=&#x02009;23.85, <em>P</em>&#x02009;=&#x02009;2.2e-005; Ribose 5-P: F (2, 15)&#x02009;=&#x02009;26.35, <em>P</em>&#x02009;=&#x02009;1.2e-005;Acetyl CoA: F (2, 15)&#x02009;=&#x02009;206.8&#x02009;<em>P</em>&#x02009;=&#x02009;1.2e-011; Citrate: F (2, 15)&#x02009;=&#x02009;8.599, <em>P</em>&#x02009;=&#x02009;0.0033; Aconitate: F (2, 15)&#x02009;=&#x02009;9.583, <em>P</em>&#x02009;=&#x02009;2.1e-003. <strong>B</strong> Heatmap showing the determination of the content of free fatty acids associated with untargeted lipid metabolomics (<em>n</em>&#x02009;=&#x02009;6). <strong>C</strong> Oil red O staining of NRVMs (scale bar: 50&#x003bc;m/10&#x003bc;m; <em>n</em>&#x02009;=&#x02009;3 independent experiments with similar results). <strong>D</strong> The mRNA expression levels of glycolysis and TCA cycle key rate-limiting enzymes HK2, IDH2 and PDH (<em>n</em>&#x02009;=&#x02009;6); F (4, 30)&#x02009;=&#x02009;208.2, <em>P</em>&#x02009;=&#x02009;2.0e-021, F (1.325, 19.87)&#x02009;=&#x02009;588.5, <em>P</em>&#x02009;=&#x02009;3.9e-017, F (2, 15)&#x02009;=&#x02009;38.78, <em>P</em>&#x02009;=&#x02009;1.2e-006, F (15, 30)&#x02009;=&#x02009;0.8990, <em>P</em>&#x02009;=&#x02009;5.7e-001. <strong>E</strong> The mRNA expression levels of key enzymes associated with fatty acid uptake and transport and mitochondrial &#x003b2;-oxidation CD36, Slc27a1, PDK4, ACOX1 and ACOT1 (<em>n</em>&#x02009;=&#x02009;6); F (8, 60)&#x02009;=&#x02009;0.1, <em>P</em>&#x02009;&#x0003e;&#x02009;9.9e-001, F (3, 41)&#x02009;=&#x02009;0.3, <em>P</em>&#x02009;=&#x02009;7.8e-001, F (2, 15)&#x02009;=&#x02009;426, <em>P</em>&#x02009;=&#x02009;6.1e-014, F (15, 60)&#x02009;=&#x02009;0.3, <em>P</em>&#x02009;=&#x02009;9.9e-001. <strong>F</strong> Western blot analysis of the glucose transport-associated proteins GLUT1 and GLUT4 and the lipid-associated transporter CD36 (<em>n</em>&#x02009;=&#x02009;6 independent experiments with similar results). <strong>G</strong>. GLUT1, GLUT4, and CD36 protein quantification levels were normalized to &#x003b2;-actin (<em>n</em>&#x02009;=&#x02009;6); CD36/&#x003b2;-actin: F (3, 20)&#x02009;=&#x02009;27.98, <em>P</em>&#x02009;=&#x02009;2.3e-007; GLUT1/&#x003b2;-actin:&#x000a0;F (3, 20)&#x02009;=&#x02009;15.61, <em>P</em>&#x02009;=&#x02009;1.8e-005; GLUT4/&#x003b2;-actin: F (3, 20)&#x02009;=&#x02009;10.23, <em>P</em>&#x02009;=&#x02009;2.7e-004. All results are shown as the mean&#x02009;&#x000b1;&#x02009;SEM, and analysis using one-way ANOVA followed by Bonferroni post hoc test (<strong>A</strong>, <strong>D</strong>, <strong>E</strong> and <strong>G</strong>) was conducted. p values are indicated. Source data are provided as a Source Data file. TCA, the tricarboxylic acid; NRVMs, neonatal rat ventricular myocytes.</p></div></div></div></div><div id="Sec7" class="sec"><h3 id="Sec7title">Sema regulates glycolipid metabolism through the downregulation of Creb5/NR4a1, downstream of PI3K/AKT, by the transcriptome</h3><p id="Par11" class="p p-first-last">To determine how Sema ameliorates cardiac remodeling under chronic load stimulation, we evaluated transcriptomic alterations in the hearts of mice in the TAC-induced and Sema-treated groups. RNA sequencing (RNA-seq) and pathway analysis of differentially expressed genes (DEGs) in left ventricular tissue revealed a strong correlation between the PI3K/AKT signaling pathway and Sema treatment (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5A</span></a>). Creb5 is a crucial component of the downstream signaling pathway of PI3K/AKT<sup><sup><a href="#CR32" rid="CR32" class=" bibr popnode">32</a></sup></sup>. It is a member of the Creb (cAMP-responsive element-binding protein) family of proteins<sup><sup><a href="#CR33" rid="CR33" class=" bibr popnode">33</a></sup></sup>. Studies have demonstrated that the Creb family plays a regulatory role in modulating the activity of NR4a1<sup><sup><a href="#CR34" rid="CR34" class=" bibr popnode">34</a></sup></sup>. We further validated the analysis of PI3K/AKT pathway-related DEGs using RNA-seq data and found that Sema significantly reduced TAC-induced activation of the transcription factors (Creb5 and NR4a1) (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5B</span></a>). We concluded that Creb5 may act as a downstream of P13K/Akt to regulate NR4a1. Further analysis via western blotting showed that PI3K, phosphorylated AKT (p-AKT, Ser 473), Creb5, NR4a1 and phosphorylated NR4a1 (p-NR4a1) levels were significantly elevated by TAC, and Sema treatment counteracted these changes (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5C</span></a>). The results revealed that TAC induced a synchronized elevation of NR4a1 in the nucleus and mitochondria (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5D</span></a>). However, the ratio of nuclear to mitochondrial NR4a1 was decreased (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5E</span></a>). Sema application increased the ratio of nuclear to mitochondrial NR4a1, suggesting that Sema reduced NR4a1 expression while decreasing its translocation to mitochondria. Immunoprecipitation experiments also determined that Creb5 and NR4a1 bind to each other in the heart (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5F</span></a>). NR4a1 has been extensively studied as a nuclear receptor<sup><sup><a href="#CR35" rid="CR35" class=" bibr popnode">35</a></sup></sup>. We found that treatment with Sema restored TAC-induced elevations in NR4a1 expression and reduced nuclear-mitochondrial translocation (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5B&#x02013;E, G, H</span></a>). These results suggest that Sema can counteract the TAC-induced activation of the PI3K/AKT/Creb5/NR4a1 signaling pathway and reduce NR4a1 nuclear-mitochondrial translocation to ameliorate TAC-induced cardiac remodeling.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig5" co-legend-rid="lgnd_Fig5"><a href="/pmc/articles/PMC11150406/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140003588746672"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11150406_41467_2024_48970_Fig5_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 41467_2024_48970_Fig5_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11150406/bin/41467_2024_48970_Fig5_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140003588746672"><a target="object" rel="noopener" href="/pmc/articles/PMC11150406/figure/Fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig5"><div><a class="figpopup" href="/pmc/articles/PMC11150406/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5">Fig. 5</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Sema can counteract the PI3K/AKT/Creb5 signaling pathway and reduce NR4a1 expression and mitochondrial-nuclear transport.</strong><p><strong>A</strong> Based on joint DEGs and Venn diagram analysis, network maps show the key molecular pathways involved in the cardiac remodeling process and regulated by Sema (<em>n</em>&#x02009;=&#x02009;3). <strong>B</strong> Heatmap showing key molecular signatures involved in the cardiac remodeling process and regulated by Sema (<em>n</em>&#x02009;=&#x02009;3). <strong>C</strong> Western blot analysis and quantification of PI3K, AKT, p-AKT, Creb5, NR4a1 and p-NR4a1 in the cardiac tissue of Sema-treated mice 8 weeks after sham or TAC surgery and quantification levels were normalized to &#x003b2;-actin (<em>n</em>&#x02009;=&#x02009;6 independent experiments with similar results); PI3K/&#x003b2;-actin: F (3, 20)&#x02009;=&#x02009;24.21, <em>P</em>&#x02009;=&#x02009;7.3e-007; pAKT/AKT: F (3, 20)&#x02009;=&#x02009;34.29, <em>P</em>&#x02009;=&#x02009;4.5e-008; Creb5/&#x003b2;-actin: F (3, 20)&#x02009;=&#x02009;17.38, <em>P</em>&#x02009;=&#x02009;8.6e-006; NR4a1/&#x003b2;-actin: F (3, 20)&#x02009;=&#x02009;6.550, <em>P</em>&#x02009;=&#x02009;0.0029; pNR4a1/&#x003b2;-actin: F (3, 20)&#x02009;=&#x02009;25.74, <em>P</em>&#x02009;=&#x02009;4.5e-007. <strong>D</strong>, <strong>E</strong> Western blot analysis and quantification of NR4a1 in mitochondrial and nuclear proteins and quantification levels were normalized NR4a1 (nuclear/mitochondrial) (<em>n</em>&#x02009;=&#x02009;6 independent experiments with similar results); NR4a1&#x000a0;(nuclear/mitochondrial): F (3, 20)&#x02009;=&#x02009;5.807, <em>P</em>&#x02009;=&#x02009;5.0e-003. <strong>F</strong> Pull-down analysis showing the binding between Creb5 and NR4a1 in vitro (<em>n</em>&#x02009;=&#x02009;6 independent experiments with similar results). <strong>G</strong>, <strong>H</strong> Representative images of MIRO1 (green) and NR4a1 (red) immunofluorescence staining in NRVMs are shown on the left, and colocalization Pearson&#x02019;s correlation coefficient (PCC) analysis is shown on the right (scale bar: 50 &#x003bc;m; <em>n</em>&#x02009;=&#x02009;3 independent experiments with similar results). All results are shown as the mean&#x02009;&#x000b1;&#x02009;SEM, and analysis using one-way ANOVA followed by Bonferroni post hoc test (<strong>C</strong> and <strong>E</strong>) was conducted. For the analysis in (<strong>G</strong> and <strong>H</strong>), a co-localization PCC analysis was used. p values are indicated. Source data are provided as a Source Data file. DEGs, differentially expressed genes; TAC, transverse aortic constriction; NRVMs, neonatal rat ventricular myocytes.</p></div></div></div></div><div id="Sec8" class="sec"><h3 id="Sec8title">NR4a1 knockdown ameliorates glucolipid metabolic disorders, mitochondrial dysfunction and pathological cardiac remodeling</h3><p id="Par12" class="p p-first-last">We further verified whether Sema affects Creb5/NR4a1 to improve TAC-induced pathological cardiac remodeling and metabolic dysfunction. First, western blotting experiments showed that AKT inhibitors counteracted the elevated expression of Creb5/NR4a1 protein after TAC (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S5A, B</a></sup>). Next, NR4a1 knockdown mice were established using AAV9-shNR4a1 to assess its role in pathological cardiac remodeling. Western blotting experiments were performed to verify the successful establishment of shRNA/shNR4a1 mice (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S6A</a></sup>). The shRNA and shNR4a1 mice were administered Sema or vector intervention under TAC induction or sham surgery for eight weeks. Echocardiographic results showed that NR4a1 deficiency attenuated TAC-induced cardiac dysfunction and increased both EF and FS (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span>6A, B</span></a>). TAC-induced chronic stress resulted in a substantial increase in CSA, whereas these parameters were significantly reduced in NR4a1 knockdown mice (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span>6C, D</span></a>). Previous studies have examined the effects of NR4a1 on mitochondrial function and structure<sup><sup><a href="#CR36" rid="CR36" class=" bibr popnode">36</a></sup></sup>. Western blotting results suggested that NR4a1 knockdown can correct the impaired myocardial mitochondrial respiratory function caused by TAC-induced chronic stress (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span>6F&#x02013;F</span></a>), as evidence ATP5a, UQCRC2, MTCO1, SDHB and NDUF88 expression were significantly upregulated after NR4a1 knockdown. Impairment of mitochondrial function and structure is closely associated with HF, while disruption of glucolipid metabolism and mitochondrial damage can influence each other<sup><sup><a href="#CR37" rid="CR37" class=" bibr popnode">37</a></sup></sup>. Then, we performed mass spectrometric metabolomic analysis of cardiac tissue from NR4a1 knockdown mice. The analysis revealed that NR4a1 knockdown counteracted the increase in glycolytic products and decreased TCA products and free fatty acid accumulation in pathological cardiac remodeling (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span>6G</span></a>). This suggests that NR4a1 knockdown alters myocardial energy substrate utilization in response to the energy demands of pathological cardiac remodeling. Overall, these results suggest that the ameliorative effects of Sema on TAC-induced pathological cardiac remodeling are mainly dependent on the regulation of NR4a1 by Sema.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig6" co-legend-rid="lgnd_Fig6"><a href="/pmc/articles/PMC11150406/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140003550372592"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11150406_41467_2024_48970_Fig6_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 41467_2024_48970_Fig6_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11150406/bin/41467_2024_48970_Fig6_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140003550372592"><a target="object" rel="noopener" href="/pmc/articles/PMC11150406/figure/Fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig6"><div><a class="figpopup" href="/pmc/articles/PMC11150406/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6">Fig. 6</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>NR4a1 knockdown ameliorates disorders of glucolipid metabolism and ameliorates pathological cardiac remodeling.</strong><p><strong>A</strong> Representative B- and M-mode echocardiographic imaging of shRNA/shNR4a1 mouse hearts. <strong>B</strong> Echocardiographic analysis of EF and ES in mice (<em>n</em>&#x02009;=&#x02009;12); EF: F (4, 55)&#x02009;=&#x02009;48.91, <em>P</em>&#x02009;=&#x02009;1.7e-017; FS: F (4, 55)&#x02009;=&#x02009;130.9, <em>P</em>&#x02009;=&#x02009;2.0e-027. <strong>C</strong>, <strong>D</strong> Myocardial hypertrophy was detected by WGA staining and then quantitatively analyzed in shRNA/shNR4a1 mice (<em>n</em>&#x02009;=&#x02009;6); F (3, 396)&#x02009;=&#x02009;2018, <em>P</em>&#x02009;=&#x02009;1.70e-239. <strong>E</strong>, <strong>F</strong> Western blot analysis and quantification of the mitochondrial respiratory chain proteins ATP5a, UQCRC2, MTCO1, SDHB and NDUF88 in the cardiac tissue of shRNA/shNR4a1 mice after sham or TAC surgery (<em>n</em>&#x02009;=&#x02009;6 independent experiments with similar results); F (12, 100)&#x02009;=&#x02009;1.789, <em>P</em>&#x02009;=&#x02009;6.0e-002, F (4, 100)&#x02009;=&#x02009;161.5, <em>P</em>&#x02009;=&#x02009;1.0e-042, F (3, 100)&#x02009;=&#x02009;62.10, <em>P</em>&#x02009;=&#x02009;9.4e-023. <strong>G</strong> Mass spectrometry-based analysis of glycolipid metabolism and TCA-related substances in shRNA/shNR4a1 mice 8 weeks after sham or TAC surgery (scale bar: 50 &#x003bc;m; <em>n</em>&#x02009;=&#x02009;6). All results are shown as the mean&#x02009;&#x000b1;&#x02009;SEM, and analysis using one-way ANOVA followed by Bonferroni post hoc test (<strong>B</strong>, <strong>D</strong> and <strong>F</strong>) was conducted. p values are indicated. Source data are provided as a Source Data file. EF, ejection fractions; FS, fractional shortening; WGA, wheat germ agglutinin; TAC, transverse aortic constriction.</p></div></div></div></div><div id="Sec9" class="sec"><h3 id="Sec9title">Knockdown of NR4a1 abrogates cardiomyocyte hypertrophy and mitochondrial functional structure in vitro</h3><p id="Par13" class="p p-first-last">To determine whether NR4a1 resists hypertrophy and ameliorates mitochondrial structure and function in isolated cardiomyocytes. We performed in vitro experiments with NRVMs and used PE to induce stress load-induced cardiac hypertrophy. We transfected NRVMs with NR4a1 siRNA or control siRNA, and the western blotting results showed successful transfection (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S7A, B</a></sup>). The immunofluorescence results showed that the control siRNA administered with PE stimulation increased cardiomyocyte size, and the mRNA levels of BNP, ANP, and &#x003b2;-MHC were significantly increased. These effects were disrupted by NR4a1 knockdown (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span>7A, B</span></a>). Then, we verified the effect of NR4a1 on mitochondria in isolated hypertrophic cardiomyocytes, and mitochondrial immunofluorescence staining showed that NR4a1 knockdown abrogated PE-induced mitochondrial division (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span>7C</span></a>). In addition, we measured the OCR of NRVMs in vitro. In the NRVMs stimulated with PE and transfected with control siRNA, oxidative respiration was significantly decreased, and ATP production decreased. However, in NRVMs transfected with NR4a1 siRNA, oxidative respiration was significantly improved, and ATP production was increased (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span>7D, E</span></a>). These results suggest that the knockdown of NR4a1 also abrogated PE-stimulated cardiomyocyte hypertrophy and mitochondrial dysfunction in vitro.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig7" co-legend-rid="lgnd_Fig7"><a href="/pmc/articles/PMC11150406/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140003539907552"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11150406_41467_2024_48970_Fig7_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 41467_2024_48970_Fig7_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11150406/bin/41467_2024_48970_Fig7_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140003539907552"><a target="object" rel="noopener" href="/pmc/articles/PMC11150406/figure/Fig7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig7"><div><a class="figpopup" href="/pmc/articles/PMC11150406/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7">Fig. 7</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>NR4a1 knockdown improves the effects of pathological cardiac remodeling and mitochondrial function in vitro.</strong><p><strong>A</strong> Immunofluorescence staining and quantification of a-actinin in NRVMs reproducing siRNA/siNR4a1 virus after PE/PBS stimulation (scale bar: 50 &#x003bc;m; <em>n</em>&#x02009;=&#x02009;3 independent experiments with similar results); F (3, 20)&#x02009;=&#x02009;86.03, <em>P</em>&#x02009;=&#x02009;1.3e-011. <strong>B</strong> The mRNA levels of the myocardial hypertrophy indicators ANP, BNP and &#x003b2;-MHC (scale bar: 50 &#x003bc;m; <em>n</em>&#x02009;=&#x02009;6); Anp: F (3, 20)&#x02009;=&#x02009;279.7, <em>P</em>&#x02009;=&#x02009;1.7e-016; Bnp: F (3, 20)&#x02009;=&#x02009;149.5, <em>P</em>&#x02009;=&#x02009;7.3e-014; &#x003b2;-MHC:&#x000a0;F (3, 20)&#x02009;=&#x02009;213.2, <em>P</em>&#x02009;=&#x02009;2.4e-015. <strong>C</strong> Representative confocal image of mitochondrial morphology stained by MitoTracker and the quantification of fragmented, intermediate, and elongated mitochondria (scale bar: 50/20 &#x003bc;m; <em>n</em>&#x02009;=&#x02009;6). <strong>D</strong> NRVMs transfected with siRNA and siNR4a1 were subjected to an OCR assay. OCR was normalized by the total number of cardiomyocytes in each group (six pore cells per group; <em>n</em>&#x02009;=&#x02009;6). <strong>E</strong> ATP production-coupled respiration in D (<em>n</em>&#x02009;=&#x02009;6); F (3, 20)&#x02009;=&#x02009;149.7, <em>P</em>&#x02009;=&#x02009;7.2e-014. All results are shown as the mean&#x02009;&#x000b1;&#x02009;SEM, and analysis using a one-way ANOVA followed by Bonferroni post hoc test (<strong>A</strong>&#x02013;<strong>C</strong> and <strong>E</strong>) was conducted. For the analysis in <strong>D</strong>, repeated measures two-way ANOVA followed by Sidak post hoc test was conducted. p values are indicated. Source data are provided as a Source Data file. PE, phenylephrine; NRVMs, neonatal rat ventricular myocytes; OCR, oxygen consumption rate; FCCP, carbonyl cyanide 4-(trifluoromethoxy)&#x000a0;phenylhydrazone.</p></div></div></div></div><div id="Sec10" class="sec sec-last"><h3 id="Sec10title">NR4a1 overexpression counteracts the ameliorative effect of Sema on pathological myocardial remodeling</h3><p id="Par14" class="p p-first-last">To provide more convincing evidence that NR4a1 in cardiomyocytes is the target for the effect of Sema on TAC-induced pathological cardiac remodeling, we established a mouse model injected with AAV9-NR4a1. We performed TAC surgery in NR4a1-overexpressed mice, and evaluated the viral efficiency in hearts 8&#x000a0;weeks later (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S6B</a></sup>), the results indicated that the heart transfection was successful, but did not significantly affect the expression of NR4a1 in the liver, kidney and brain (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S6B</a></sup>, Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S6E</a></sup>). As expected, overexpression of NR4a1 in cardiomyocytes did not exacerbate the TAC-induced reduction in LVEF and LVFS but counteracted the therapeutic effect of Sema on TAC-induced cardiac dysfunction (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig8" rid-ob="ob-Fig8" co-legend-rid="lgnd_Fig8"><span>8A, B</span></a>). After TAC surgery, the myocardial size and CSA of mice treated with AAV9-NR4a1 injection were also not reduced after Sema treatment (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig8" rid-ob="ob-Fig8" co-legend-rid="lgnd_Fig8"><span>8C&#x02013;E</span></a>). Furthermore, we detected the protein levels of mitochondrial respiratory chain complexes in cardiac tissues from mice with NR4a1 overexpression and those with NR4a1 knockdown and found that mitochondrial respiratory function improved in Sema-treated mice with or without NR4a1 knockdown eight weeks after TAC. In contrast, mitochondrial respiration-related protein was inhibited in mice overexpressing NR4a1 with or without Sema treatment (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S6C&#x02013;D</a></sup>). Overall, these data suggest that NR4a1 overexpression alone does not exacerbate TAC-induced pathological cardiac remodeling but counteracts the therapeutic effect of Sema, further confirming that NR4a1 is a target of Sema in pressure overload-induced cardiac remodeling and dysfunction.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig8" co-legend-rid="lgnd_Fig8"><a href="/pmc/articles/PMC11150406/figure/Fig8/" target="figure" rid-figpopup="Fig8" rid-ob="ob-Fig8"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140003552249424"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11150406_41467_2024_48970_Fig8_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 41467_2024_48970_Fig8_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11150406/bin/41467_2024_48970_Fig8_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140003552249424"><a target="object" rel="noopener" href="/pmc/articles/PMC11150406/figure/Fig8/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig8"><div><a class="figpopup" href="/pmc/articles/PMC11150406/figure/Fig8/" target="figure" rid-figpopup="Fig8" rid-ob="ob-Fig8">Fig. 8</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>NR4a1 overexpression exacerbates cardiac remodeling and dysfunction in mice that underwent TAC for eight weeks.</strong><p><strong>A</strong> Representative B- and M-mode ultrasound images of AAV9-NC and AAV9-NR4a1 mice 8 weeks after sham or TAC surgery. <strong>B</strong> Echocardiographic analysis of EF, FS, LVIDd and LVIDs in mice (<em>n</em>&#x02009;=&#x02009;12); EF: F (3, 44)&#x02009;=&#x02009;24.81, <em>P</em>&#x02009;=&#x02009;1.5e-009; FS: F (3, 44)&#x02009;=&#x02009;13.84, <em>P</em>&#x02009;=&#x02009;1.7e-006; LVIDd:&#x000a0;F (3, 44)&#x02009;=&#x02009;4.115, <em>P</em>&#x02009;=&#x02009;1.2e-002; LVIDs: F (3, 44)&#x02009;=&#x02009;7.995, <em>P</em>&#x02009;=&#x02009;0.0002. <strong>C</strong> Representative histopathological cross-sectional images of mouse hearts (scale bar: 2&#x02009;mm; <em>n</em>&#x02009;=&#x02009;6). <strong>D</strong>, <strong>E</strong> Myocardial hypertrophy was detected by WGA staining and then quantitatively analyzed (scale bar: 50 &#x003bc;m; <em>n</em>&#x02009;=&#x02009;6); F (3, 20)&#x02009;=&#x02009;5.364, <em>P</em>&#x02009;=&#x02009;0.0071. All results are shown as the mean&#x02009;&#x000b1;&#x02009;SEM, and analysis using one-way ANOVA followed by Bonferroni post hoc test (<strong>B</strong> and <strong>E</strong>) was conducted. p values are indicated. Source data are provided as a Source Data file. AAV9,&#x000a0;adeno-associated virus 9; TAC, transverse aortic constriction; EF, ejection fractions; FS, fractional shortening; LVIDd, diastolic left ventricular internal diameters; LVIDs, systolic left ventricular internal diameters; WGA, wheat germ agglutinin.</p></div></div></div></div></div><div id="Sec11" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec11title">Discussion</h2><p id="Par15" class="p p-first">Although numerous studies have shown that cardiac energy metabolism is altered in pathological cardiac remodeling and that the resulting myocardial energy deficit can lead to further HF, there is minimal research on therapeutic targets and drugs based on this energy shift<sup><sup><a href="#CR2" rid="CR2" class=" bibr popnode">2</a></sup>,<sup><a href="#CR38" rid="CR38" class=" bibr popnode">38</a></sup></sup>. Sema ameliorated and reversed the cardiac dysfunction of myocardium remodeling induced by chronic stress loading and significantly reduced cardiomyocyte volume and matrix collagen deposition. Vacuolization, swelling, and cristae breaks of mitochondria were observed in pressure-overloaded hearts. These alterations trigger disorders in the mitochondrial oxidative respiratory chain and ATP production capacity. However, these disorders can be treated and prevented by Sema. These data suggest that changes in mitochondrial structure and function induce a metabolic paradigm shift. This allows more glucose to enter the glycolytic process but not be fully oxidized. This occurs in parallel with a decrease in fatty acid consumption, resulting in lipid accumulation. The role of the pyruvate-lactate axis metabolic pattern in the control of hypertrophy has been reported<sup><sup><a href="#CR39" rid="CR39" class=" bibr popnode">39</a></sup></sup>. In contrast, we found that Sema decreases glycolysis and free fatty acid accumulation by maintaining mitochondrial function and promoting the TCA cycle to increase the energy supply. Mechanistically, we demonstrated that Sema exerts its regulatory effect on myocardial energy metabolism via the regulation of Creb5/NR4a1 in vitro and in vivo. Transcriptional activation of NR4a1 by Creb5 disturbed the balance of glycolipid metabolism and promoted glycolysis and lipid accumulation. Sema can counteract the transcriptional activation of Creb5/NR4a1 in myocardium remodeling. In summary, we conclude that Sema is a potential drug that can improve myocardial energy metabolism in pathological cardiac remodeling and thus achieve therapeutic effects.</p><p id="Par16">The majority of ATP in the healthy heart is derived from mitochondrial oxidative metabolism, whereas the end-stage failing heart undergoes a drastic shift in energy metabolism. Van Bilsen et al. proposed that in the initiation of HF, myocardial fatty acid, glucose, ketone body, and branched-chain amino acid metabolism is disturbed, leading to alterations in myocardial structure and function<sup><sup><a href="#CR26" rid="CR26" class=" bibr popnode">26</a></sup>,<sup><a href="#CR40" rid="CR40" class=" bibr popnode">40</a></sup></sup>. Moreover, metabolic disturbances contribute to the disruption of mitochondrial morphology and function. Subsequently, metabolic changes and loss of mitochondrial function reinforce each other and further aggravate the process of HF<sup><sup><a href="#CR24" rid="CR24" class=" bibr popnode">24</a></sup>,<sup><a href="#CR41" rid="CR41" class=" bibr popnode">41</a></sup></sup>. Fusion and fission cycles are critical for mitochondrial function and biogenesis. OPA1 is obligatory for the regulation of mitochondrial inner membrane fusion, and Mfn1/2 coordinates mitochondrial outer membrane integration<sup><sup><a href="#CR42" rid="CR42" class=" bibr popnode">42</a></sup></sup>. However, fission is executed by Drp1 in response to various physiological cues<sup><sup><a href="#CR43" rid="CR43" class=" bibr popnode">43</a></sup></sup>. Consistently, enhanced O-GlcNAcylation of Drp1 in failing hearts promotes mitochondrial fragmentation and inhibits mitochondrial DNA repair<sup><sup><a href="#CR44" rid="CR44" class=" bibr popnode">44</a></sup></sup>. Sema has an ameliorative effect on metabolic disorders in patients with obesity, but the mechanism is unknown. In contrast, we found that Sema regulates the expression of mitochondrial regulatory proteins, reduces mitochondrial fission, and restores the expression of mitochondrial respiration-related complex proteins in response to stress. Our study verified that Sema markedly improved mitochondrial morphology and function in HF (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5</span></a>), which may provide a mechanism for Sema to act on metabolic disorders.</p><p id="Par17">Myocardial energy substrates are biased towards glycolysis to ensure a continuous energy output. Increased glycolysis increases pyruvate production, but reduced pyruvate oxidation leads to a reduction in substrates entering the TCA to produce ATP. Excess pyruvate produces lactic acid, and high lactate levels increase visceral fibrosis and cardiac dysfunction<sup><sup><a href="#CR45" rid="CR45" class=" bibr popnode">45</a></sup></sup>. A decrease in the expression of fatty acid transporter proteins and key rate-limiting enzymes of &#x003b2;-oxidation impairs fatty acid oxidation. The mismatch between uptake and oxidation results in lipid accumulation, thereby producing unfavorable lipid substances, such as ceramides and diacylglycerols. This lipid accumulation leads to mitochondrial dysfunction, which in turn exacerbates HF<sup><sup><a href="#CR41" rid="CR41" class=" bibr popnode">41</a></sup></sup>. Fatty acid accumulation causes insulin resistance through insulin signaling cascades, which counteracts increased glucose uptake and glycolysis<sup><sup><a href="#CR46" rid="CR46" class=" bibr popnode">46</a></sup></sup>. Glucose serves as the most efficient energy substrate (ATP production/O<sub>2</sub> consumption). Theoretically, increased glucose utilization could alleviate HF energy deficiency. Nevertheless, we found a reduction in the expression of fatty acid transport proteins (e.g., CD36) and &#x003b2;-oxidation key rate-limiting enzymes (e.g., ACOX1) upon pressure overload, which caused a reduction in fat oxidation and fatty acid accumulation (Fig. &#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4</span></a>B, <a href="/pmc/articles/PMC11150406/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">B,E).</span></span><span>E</span></a>). Simultaneously, mitochondrial respiratory chain-associated complexes (e.g., ATP synthase) function abnormally and deter complete glucose oxidation (Figs. &#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3</span></a>A, <a href="/pmc/articles/PMC11150406/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1em;">A,4A).</span></span><span>4A</span></a>). Increased myocardial glycolysis leads to enhanced O-GlcNAcylation-mediated mitochondrial dysfunction and structural damage<sup><sup><a href="#CR47" rid="CR47" class=" bibr popnode">47</a></sup></sup>. However, O-GlcNAcylation interferes with electron transport chain processes and enzymes involved in aerobic respiration, further interfering with substrate oxidation processes<sup><sup><a href="#CR33" rid="CR33" class=" bibr popnode">33</a></sup>,<sup><a href="#CR48" rid="CR48" class=" bibr popnode">48</a></sup></sup>. Moreover, the upregulation of glycolytic bypass pathways, such as Hexosamine Biosynthetic Pathway (HBP), exacerbates glycation levels and contributes to cardiac hypertrophy<sup><sup><a href="#CR49" rid="CR49" class=" bibr popnode">49</a></sup></sup>. Based on the reduced fatty acid oxidation and lipid accumulation in the remodeled myocardium, can we increase fatty acid oxidation to reverse cardiac function? Surprisingly, clinical trials have shown that beta-lipid-lowering drugs do not affect new-onset HF<sup><sup><a href="#CR50" rid="CR50" class=" bibr popnode">50</a></sup></sup>. Furthermore, the use of acipimox (a lipolytic inhibitor), which substantially reduces free fatty acids but causes a sudden decline in cardiac function in patients with dilated cardiomyopathy, has no effect on healthy individuals<sup><sup><a href="#CR51" rid="CR51" class=" bibr popnode">51</a></sup></sup>. We can conclude that directly reversing the metabolism of the failing heart back to fatty acid oxidation as a substrate for myocardial energy may instead be detrimental to cardiac function. Therefore, directly promoting glucose oxidation, rather than reversing it to normal metabolism, may be more useful to improve energy metabolism in the failing heart.</p><p id="Par18">The ongoing quest for efficacious treatments in HF has underscored the imperative need for therapeutic agents capable of enhancing mitochondrial function and promoting glucose oxidation, thereby addressing the critical energy deficit prevalent among HF patients. Despite the potential of certain compounds, such as DCA and elamipretide, to augment these metabolic pathways, their clinical application remains constrained by adverse toxicological profiles and insufficient efficacy in patient populations<sup><sup><a href="#CR10" rid="CR10" class=" bibr popnode">10</a></sup>,<sup><a href="#CR12" rid="CR12" class=" bibr popnode">12</a></sup></sup>. This delineates a significant therapeutic void, necessitating the exploration of compounds with minimized side effects and heightened clinical action. Further expanding our understanding of metabolic regulation post-myocardial infarction, GLP-1RA have emerged as vital players<sup><sup><a href="#CR52" rid="CR52" class=" bibr popnode">52</a></sup></sup>. Untargeted metabolomic analyzes conducted on the ventricles of infarcted mice reveal that mitochondria and metabolism constitute the principal targets of short-acting GLP-1RA therapy in the aftermath of an infarction<sup><sup><a href="#CR53" rid="CR53" class=" bibr popnode">53</a></sup>,<sup><a href="#CR54" rid="CR54" class=" bibr popnode">54</a></sup></sup>. In this context, our study introduces Sema as a promising candidate poised to bridge this gap. Notably, Sema has demonstrated its potential by engaging in the regulation of the oxidative respiratory chain complex. This involves key processes such as the dimerization of ATP synthase (Complex V), a pivotal step in maintaining mitochondrial function and morphology. Such regulatory mechanisms are crucial for enhancing ATP production, which in turn meets the increased myocardial energy demands by attenuating free fatty acid concentrations and optimizing the TCA cycle.</p><p id="Par19">Acetyl coenzyme A, which is increased during glycolysis, is one of the substrates of glycosylation (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4A</span></a>). The glycolytic bypass HBP pathway is increased after TAC, and glycosylation levels are increased<sup><sup><a href="#CR49" rid="CR49" class=" bibr popnode">49</a></sup></sup>. However, the increases in glycosylation levels due to HBP can increase susceptibility to HF<sup><sup><a href="#CR55" rid="CR55" class=" bibr popnode">55</a></sup></sup>. The PPP produces lipid precursors, promotes nucleotide metabolism and increases NADPH production<sup><sup><a href="#CR56" rid="CR56" class=" bibr popnode">56</a></sup></sup>. However, G6PD glycosylation reduces the production of NADPH, allowing elevations in the PPP that promote lipid and nucleotide synthesis<sup><sup><a href="#CR57" rid="CR57" class=" bibr popnode">57</a></sup></sup>. Moreover, nucleotide metabolism and cardiomyocyte hypertrophy are closely related<sup><sup><a href="#CR58" rid="CR58" class=" bibr popnode">58</a></sup></sup>. This suggests that HBP and PPP products may interact to influence cardiac hypertrophy. Our study confirms this conjecture, as the activation of the PPP was consistent with lipid accumulation and cellular hypertrophy (Figs. &#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a> and <a href="/pmc/articles/PMC11150406/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and4</span></span><span>4</span></a>).</p><p id="Par20">NR4a1 is a pivotal transcription factor that plays a significant role in pathological myocardial remodeling. Reduced expression of NR4a1 and its dependent activation of the HBP have been shown to mitigate adverse myocardial remodeling<sup><sup><a href="#CR59" rid="CR59" class=" bibr popnode">59</a></sup></sup>. Additionally, NR4a1 has been identified as a key regulator in inhibiting cardiac fibrosis following myocardial infarction by modulating glycolysis<sup><sup><a href="#CR60" rid="CR60" class=" bibr popnode">60</a></sup></sup>. Despite its crucial functions, NR4a1 lacks an identified endogenous ligand<sup><sup><a href="#CR61" rid="CR61" class=" bibr popnode">61</a></sup></sup>. Studies have identified several structurally diverse compounds that activate or inactivate nuclear NR4a1<sup><sup><a href="#CR62" rid="CR62" class=" bibr popnode">62</a></sup></sup>. Notably, Cytosporone B, a natural agonist for NR4a1, has been explored for its therapeutic potential in cancer and fibrosis-related diseases<sup><sup><a href="#CR63" rid="CR63" class=" bibr popnode">63</a></sup></sup>. Moreover, the compound ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl) phenyl] acetate (TMPA) has demonstrated antagonistic effects on NR4a1 function in diabetic mice, offering promising avenues for metabolic disorder management<sup><sup><a href="#CR64" rid="CR64" class=" bibr popnode">64</a></sup></sup>. However, the implications of these compounds for nuclear transcription modulation of NR4a1 and their effects on nuclear translocation within the context of cardiovascular disease remain unexplored. The dual nature of NR4a1&#x02019;s activity necessitates a balanced approach to its modulation, reflecting the variable trends observed across different experimental models. The regulation of NR4a1 extends beyond direct modulators, involving critical signaling pathways such as PI3K/AKT and downstream factors like Creb<sup><sup><a href="#CR65" rid="CR65" class=" bibr popnode">65</a></sup></sup>. Creb has been implicated in neuroinflammation amelioration and blood-brain barrier stabilization post-intracerebral hemorrhage through NR4a1 regulation<sup><sup><a href="#CR34" rid="CR34" class=" bibr popnode">34</a></sup></sup>. Given Creb5&#x02019;s role as an important downstream effector of PI3K/AKT and a member of the Creb family, the potential regulatory influence of Creb5 on NR4a1 warrants investigation. Our study introduces Sema, highlighting its capacity to correct abnormal NR4a1 expression mediated by Creb5 in the TAC model, thus ameliorating metabolic dysregulation associated with myocardial remodeling. Transcriptomic analyzes have further elucidated the dependency of Sema&#x02019;s therapeutic effects on the Creb5/NR4a1 axis, specifically in the regulation of glycolipid metabolism during pathological myocardial remodeling (Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5</span></a>).</p><p id="Par21">Notably, NR4a1&#x02019;s translocation from the nucleus to mitochondria underscores its vital role in mitochondrial function regulation<sup><sup><a href="#CR66" rid="CR66" class=" bibr popnode">66</a></sup></sup>, suggesting that targeting NR4a1 to improve metabolism may offer significant therapeutic benefits. Our research demonstrated increased NR4a1 expression and phosphorylation under stress conditions, accompanied by its nuclear-to-mitochondrial translocation, thereby disrupting mitochondrial integrity (Figs. &#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5</span></a> and <a href="/pmc/articles/PMC11150406/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and6).</span></span><span>6</span></a>). Through the employment of adenoviral constructs for NR4a1 knockout and overexpression, we validated Sema&#x02019;s beneficial effects on glucolipid metabolism and mitochondrial dysfunction in pathological myocardial remodeling via NR4a1 modulation (Figs. &#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span>6</span></a>&#x02013;<a href="/pmc/articles/PMC11150406/figure/Fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig8" rid-ob="ob-Fig8" co-legend-rid="lgnd_Fig8"><span>8</span></a>). Sequencing data from the Sema reversal experiment indicated a consistent trend in genes within the Creb5/NR4a1 pathway with those observed in initial Sema treatment, highlighting the significance of this regulatory axis (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S2C</a></sup>, Fig.&#x000a0;<a href="/pmc/articles/PMC11150406/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5B</span></a>). Moreover, the regulation of cell migration, primarily mediated by the MAPK and ERK cascades (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S2E</a></sup>), was validated to influence myofibroblast behavior through NR4a1 modulation<sup><sup><a href="#CR67" rid="CR67" class=" bibr popnode">67</a></sup></sup>. Moreover, metformin&#x02019;s ability to ameliorate hyperglycemia-induced endothelial dysfunction by modulating NR4a1<sup><sup><a href="#CR68" rid="CR68" class=" bibr popnode">68</a></sup></sup>, suggests a close relationship between NR4a1 and vascular development. Additionally, NR4a1 is implicated in high-fat-associated endothelial dysfunction through the promotion of the CaMKII-Parkin-mitochondrial autophagy pathway in endothelial cells<sup><sup><a href="#CR69" rid="CR69" class=" bibr popnode">69</a></sup></sup>, highlighting the importance of mitochondrial pathway regulation by NR4a1. The intricate relationship between NR4a1 and various metabolic and cellular pathways underscores its therapeutic potential, particularly in myocardial remodeling and associated metabolic disorders. Our findings concerning Sema&#x02019;s modulation of NR4a1 through the Creb5 pathway offer insights into potential treatments for cardiovascular diseases, paving the way for future research in this domain.</p><p id="Par22">The map of drug targeting at single-cell predicts the Sema showed strongest effects on P cells compared with other cardiac cells. And P cells were found to promote autonomic nervous activity through nerve growth factor (NGF) signaling<sup><sup><a href="#CR70" rid="CR70" class=" bibr popnode">70</a></sup></sup>. Acetylcholine released by autonomic nervous of the vagal nerve in hearts mainly acts on myocardial M muscarinic receptors. In the cardioprotection provided by remote ischemic regulation, the vagus nerve stimulates intestinal peptide secretion of GLP-1, and then GLP-1R activation reduces the size of myocardial infarction by a mechanism involving M muscarinic receptors<sup><sup><a href="#CR71" rid="CR71" class=" bibr popnode">71</a></sup></sup>. M muscarinic receptor activation has been shown to improve cardiac function in various heart diseases<sup><sup><a href="#CR72" rid="CR72" class=" bibr popnode">72</a></sup>,<sup><a href="#CR73" rid="CR73" class=" bibr popnode">73</a></sup></sup>. Additionally, recent research has included muscarinic receptor activation as a potential cardiac beneficial signaling pathway in the analysis of myocardial transcriptomics in mice with myocardial infarction<sup><sup><a href="#CR74" rid="CR74" class=" bibr popnode">74</a></sup></sup>. Therefore, we speculate that the protective effect of Sema in myocardium remodeling may also be related to the activation of M muscarinic receptors. We performed M muscarinic receptor blockade experiments with Atro and found that the improvement of Sema on cardiac function were significantly blocked by Atro (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S8</a></sup>), and Atro blockade does not affect the weight loss effect of Sema (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">S8A</a></sup>), which also suggests that the effect of Sema on the heart may be independent of its effect on body weight. Recent studies have confirmed that the anti-inflammatory benefits of Sema require GLP-1R in the central nervous system (CNS), and Atro blocks do not affect the anti-inflammatory effects of GLP-1RA<sup><sup><a href="#CR75" rid="CR75" class=" bibr popnode">75</a></sup></sup>. This difference may be due to the fact that GLP-1R in the CNS is predominantly located on neurons and GLP-1R in the heart is predominantly located on P cells, and the physiological functions of the two types of cells are very different. In summary, we believe that Sema may exert cardioprotective effects by activating GLP-1R expressed by P cells, triggering the release of acetylcholine, and regulating ventricular function by activating M muscarinic receptors. Although this conclusion is not supported by exhaustive experiments, these findings still provide the possibility that Sema modulates ventricular muscle through acetylcholine.</p><p id="Par23" class="p">In conclusion, as GLP-1RA glucose-lowering drugs have been increasingly used in clinical practice, their cardiovascular benefits have also been identified. Our study validated the clinically relevant finding that Sema, a GLP-1RA, has significant therapeutic effects on pathological myocardial remodeling. More importantly, Sema was shown to regulate myocardial energy metabolism based on the regulation of NR4a1 in pathological cardiac remodeling. Specifically, Sema not only reduces glycolysis and free fatty acid accumulation but also increases glucose oxidation and promotes the conversion of its metabolite pyruvate to the TCA&#x000a0;cycle. Thus, the TCA produces more ATP for myocardial energy supply, which ameliorates hypertrophy, fibrosis and cardiac dysfunction in pathological cardiac remodeling. In conclusion, this study not only identifies Sema as a potential therapeutic agent for pathological myocardial remodeling but also suggests NR4a1 as a key target for regulating the myocardial glucolipid metabolic pathway. More importantly, the study may have valuable implications for patients with HF with obesity in clinical practice.</p><div id="Sec12" class="sec sec-last"><h3 id="Sec12title">Limitations of the study</h3><p id="Par24" class="p p-first-last">In this comprehensive evaluation of Sema&#x02019;s impact on myocardial remodeling, our investigation employed a dose-response approach, administering 4.0, 12.0, or 60.0&#x02009;mg/kg/day of Sema. The findings highlight a dose-dependent reduction in body weight across these doses without liver function compromise (Fig. <sup><a href="#MOESM1" rid="MOESM1" class=" media">1</a></sup>), with both the lowest and highest doses of Sema providing protective effects against pathological myocardial remodeling. Interestingly, the intermediate dose of 12.0&#x02009;mg/kg/day was associated with diminished cardiac function, suggesting a nuanced relationship between Sema dosage and cardiac health that warrants further exploration to understand the underlying mechanisms fully. Moreover, the exclusive use of male mice limits the generalizability of these findings across genders, pointing to the need for gender-inclusive studies to fully ascertain the therapeutic potential of Sema. Furthermore, while the TAC model is a robust method for simulating pressure overload-induced cardiac hypertrophy in rodents<sup><sup><a href="#CR76" rid="CR76" class=" bibr popnode">76</a></sup></sup>, it falls short of capturing the multifaceted etiology of human cardiac disease, including genetic predispositions and susceptibility factors. This limitation emphasizes the importance of employing diverse experimental models to enhance our understanding of Sema&#x02019;s therapeutic implications in a broader, more clinically relevant context.</p></div></div><div id="Sec13" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec13title">Methods</h2><div id="Sec14" class="sec sec-first"><h3 id="Sec14title">Animals</h3><p id="Par25" class="p p-first-last">All animal experiments were performed using male mice to ensure that sex difference influences were excluded, and all animals were housed in specific pathogen-free (SPF) facilities condition with 20-25 &#x000b0;C temperature and 45-55% humidity on a regular 12-hour lightdark cycle, and approved by the Animal Welfare Ethics Committee at Renmin Hospital of Wuhan University (No. WDRM20220803B). All mice were fed with an irradiated chow diet (#1035 for reproductive feeding and #1025 for maintenance feeding, Beijing HFK Bioscience Co., Ltd, Beijing, China), with free access to drinking water. C57BL/6&#x02009;J male mice were purchased from the Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (Beijing, China). The 8-week-old male mice were acclimated in a quarantine room for 1 week before the subsequent experiments. In the TAC surgical induce model of pathological myocardial remodeling under chronic pressure overload, all the male mice injected with Sema and its vehicle underwent TAC surgery or sham surgery as a control group<sup><sup><a href="#CR77" rid="CR77" class=" bibr popnode">77</a></sup></sup>. Sema was purchased from the Master of Bioactive Molecules, and was used based on available studies and biopotency conversions<sup><sup><a href="#CR78" rid="CR78" class=" bibr popnode">78</a></sup>,<sup><a href="#CR79" rid="CR79" class=" bibr popnode">79</a></sup></sup>. Mice were injected intraperitoneally with doses of 4.0, 12.0 or 60.0&#x02009;&#x003bc;g/kg/day or the control drug-solution vehicle for eight weeks for subsequent experiments<sup><sup><a href="#CR79" rid="CR79" class=" bibr popnode">79</a></sup></sup>. Atropine (Atro) was purchased from the Master of Bioactive Molecules. The male mice were intraperitoneally injected with Atro 1&#x02009;mg/kg/day for blocking M muscarinic receptors. Body weight was monitored and recorded weekly.</p></div><div id="Sec15" class="sec"><h3 id="Sec15title">Adeno-associated virus 9 construction of NR4a1 overexpression or knockdown mouse model</h3><p id="Par26" class="p p-first-last">To specifically knock down NR4a1 in cardiomyocytes, adeno-associated virus 9 (AAV9) carrying short hairpin NR4a1 (AAV9-shNR4a1) with cTNT as the promoter and its control vector (AAV9-shRNA) were constructed by Design Gene Biotechnology (Shanghai, China). The AAV9-shNR4a1 or AAV9-shRNA was orbitally injected at 50&#x02009;&#x003bc;l per mouse (1&#x000d7;10<sup>13</sup> pfu/ml). To specifically overexpress NR4a1 in cardiomyocytes, AAV9 carrying NR4a1 (AAV9-NR4a1) genomic particles and vector with green fluorescent protein (AAV9-NC) were injected in male mice via orbital veins. One week later, TAC surgery was performed and Sema treatment was administered. Then, the heart was collected eight weeks after the administration of the treatment.</p></div><div id="Sec16" class="sec"><h3 id="Sec16title">Echocardiograph</h3><p id="Par27" class="p p-first">Echocardiography was performed at 4 or 8 weeks after TAC. Echocardiography was analyzed with a 10-MHz linear array ultrasound transducer equipped with a 30-MHz probe (Vevo 3100 system Visual Sonics)<sup><sup><a href="#CR77" rid="CR77" class=" bibr popnode">77</a></sup>,<sup><a href="#CR80" rid="CR80" class=" bibr popnode">80</a></sup></sup>. First, the mice were anaesthetised with a mixture of 4% isoflurane and 0.5&#x02009;L/min oxygen. Conductive adhesive was applied to the copper plate of the physiological information monitoring table and the paws of the mice were secured to obtain electrocardiogram (ECG) and respiratory information. The probe was positioned in the parasternal short-axis view and M-mode ultrasound images were acquired for left ventricular internal dimension at end-diastole&#x000a0;and end-systole (LVIDd and LVIDs). Multiple cardiac cycles were tracked and traced along the endocardial (Endo) trajectory of the anterior wall of the LV, and then the Endo of the posterior wall of the LV was similarly traced. On this basis, the following calculated values can be obtained: LV end-diastolic volume (EDV), LV end-systolic volume (ESV), stroke volume, ejection fractions (EF) and fractional shortening (FS). Notably, the LVFS was calculated by the formula: LVFS= (LVIDd&#x02212;LVIDs)&#x000d7;100/LVIDd. The LVEF was also evaluated using the Teichholtz formula: LVEF&#x02009;=&#x02009;([100&#x02009;&#x02212;&#x02009;Y]&#x000d7;0.15)&#x02009;+&#x02009;Y; Y&#x02009;=&#x02009;(LVIDd<sup>2</sup>&#x02009;&#x02212;&#x02009;LVIDs<sup>2</sup>)&#x000d7;100/LVIDd<sup>2</sup>.</p><p id="Par28" class="p p-last">The maximum rate of isovolumetric systolic LV pressure increase (&#x02009;+&#x02009;dp/dt max) and maximum rate of isovolumetric diastolic LV pressure decrease (-dp/dt max) were also counted. For subsequent data statistics, three to five consecutive cardiac cycles were recorded continuously in the presence of nonrespiratory spikes. After the echocardiogram, mice were euthanized under anesthesia (pentobarbital sodium 80&#x02009;mg/kg; intraperitoneal). Peripheral blood was collected, hearts and lungs were weighed, and tibial length was measured. The intact hearts were immersed in 10% potassium chloride and arrested in diastole. Then, the hearts were soaked in formalin for subsequent pathology-related experiments in kerosene sections. Left ventricular tissue from the mice was harvested for subsequent fractionation, transcriptional sequencing and metabolic mass spectrometry.</p></div><div id="Sec17" class="sec"><h3 id="Sec17title">Neonatal rat ventricular myocyte isolation and culture</h3><p id="Par29" class="p p-first-last">Neonatal rat ventricular cardiomyocytes (NRVMs) were isolated from the hearts of three-day-old neonatal suckling rats<sup><sup><a href="#CR77" rid="CR77" class=" bibr popnode">77</a></sup></sup>. In brief, the neonatal rats were euthanised with isoflurane and then the hearts were harvested. Hearts were treated 3-4 times at 37&#x02009;&#x000b0;C with fresh Ca<sup>2&#x02009;+</sup>&#x02009;-free HBSS solution containing 0.125% trypsin to isolate cardiac tissue. The supernatant containing the isolated cells was collected and centrifuged at 1200&#x02009;rpm for 8&#x02009;minutes. The supernatant is gently aspirated and medium is added to mix the cells. The isolated cells were cultured for 1&#x02009;hour in DMEM containing 1.0&#x02009;g/L D-glucose, 10% FBS, 100&#x02009;U/mL penicillin and 0.1&#x02009;mg/mL streptomycin. Cardiomyocytes suspended in the supernatant were then collected and transferred to six-well or 24-well plates and placed in a 5% CO<sub>2</sub> incubator at 37&#x02009;&#x000b0;C for subsequent studies. Simulating the effects of in vitro drug treatment, phenylephrine (PE) stimulation was given for 48&#x02009;hours, and drug treatment was given for 48&#x02009;hours. Small siRNA oligonucleotides (RiboBio, Guangzhou, China) were transfected with Lipo-6000 reagent (Beyotime Biotechnology, China) according to the manufacturer&#x02019;s instructions. Western blotting assays were performed to demonstrate the potency of the transfected siRNA.</p></div><div id="Sec18" class="sec"><h3 id="Sec18title">Blood glucose measurements and glucose tolerance test</h3><p id="Par30" class="p p-first-last">In the modeled mice, the blood glucose levels in both standard and diabetic animals were determined using a kit reagent (Exactech blood glucose strip) according to the glucose oxidase method. Fasting blood glucose measurements were performed weekly. After the mice were fasted, blood glucose was measured using glucose test strips (Roche, Mannheim, Germany). Briefly, the tip of the tail of the mice was cut with scissors, the first drop of blood was discarded, and the effluent blood was placed on a blood glucose test strip for blood glucose measurement. The glucose tolerance test (GTT) was performed one week before collecting peripheral blood and hearts. Specifically, mice were fasted overnight, and blood glucose levels were measured at five time points: 15, 30, 60, 90 and 120&#x02009;minutes after intraperitoneal glucose injection.</p></div><div id="Sec19" class="sec"><h3 id="Sec19title">Total cholesterol, triglycerides, alanine transaminase and aspartate transaminase measurements</h3><p id="Par31" class="p p-first-last">Orbital venous blood was collected from experimental mice and centrifuged for plasma. Enzymatic kit reagents were purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China) and used to determine total cholesterol and triglycerides (TG). Serum concentrations of the liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were determined by an automated biochemical analyzer (ADVIA&#x000ae; 2400 Siemens Ltd, Tarrytown, NY, USA)<sup><sup><a href="#CR81" rid="CR81" class=" bibr popnode">81</a></sup></sup>.</p></div><div id="Sec20" class="sec"><h3 id="Sec20title">Measuring mitochondrial respiratory function with OCR</h3><p id="Par32" class="p p-first-last">To observe mitochondrial respiratory function, the above isolated NRVMs were cultured in cell dishes for 48&#x02009;hours and placed in wells coated with 1% Matrigel for analysis with Seahorse BioSciences XF<sup>e</sup> 24 Extracellular Flux Analyzers (Seahorse BioSciences Asia, Pudong, Shanghai). After stimulating the cells with PE or Sema, measurements were taken for five consecutive days with daily medium changes, and the oxygen consumption rate (OCR) was measured using the Cell Mito Stress Kit (Seahorses Biosciences, 103015). Data were normalized to the number of cells measured on culture plates by 4-pyr6-diamino-2-phenylindole (DAPI) staining according to the Seahorse Cell Mito Stress Kit protocol with oligomycin final concentration of 1.5&#x02009;&#x000b5;M, FCCP final concentration of 2.5&#x02009;&#x000b5;M, and rotenone/antimycin A final concentration of 0.5&#x02009;&#x000b5;M.</p></div><div id="Sec21" class="sec"><h3 id="Sec21title">Histological analysis and immunofluorescence staining of tissues and cells</h3><p id="Par33" class="p p-first-last">Cardiac tissue that had been fixed in sections was stained with picrosirius red (PSR), and collagen volume was measured for analysis. Hematoxylin-eosin staining (HE) and wheat germ agglutinin (WGA) staining were used to observe the extent of hypertrophy in the mouse myocardium in vivo. Successfully stimulated NRVMs were incubated overnight at 4&#x02009;&#x000b0;C with primary antibodies against a-actinin (Abcam #ab108198 1:1000), NR4a1 (CST #3960 1:1000) or anti-MIRO1 (ABCAM #ab188029 1:1000)<sup><sup><a href="#CR82" rid="CR82" class=" bibr popnode">82</a></sup></sup>. The next day, treated with secondary antibodies (goat anti-mouse IgG Alexa Fluor 488 secondary antibodies Invitrogen #A11001 IF 1:200; goat anti-rabbit lgG Alexa Fluor 568 secondary antibodies Invitrogen #A11011 IF 1:200)for 60&#x02009;min at 37&#x000b0;C, the nuclei were stained with DAPI and sealed for photographic purposes. PSR and HE images were acquired with an Aperio VERSA 8 (Leica Biosystems), and immunofluorescence and WGA images were acquired with an Olympus BX53. All images were analyzed using Image-Pro Plus 6.0.</p></div><div id="Sec22" class="sec"><h3 id="Sec22title">Transmission electron microscopy (TEM) imaging and mitochondrial morphology assessment</h3><p id="Par34" class="p p-first-last">TEM and mitochondrial morphological protocols were performed based on our previous studies on mitochondria<sup><sup><a href="#CR83" rid="CR83" class=" bibr popnode">83</a></sup></sup>. After successful modeling, the mice were anesthetized and euthanized after eight weeks of TAC. The hearts were quickly removed and placed in freezing tubes in liquid nitrogen for subsequent cutting. Left ventricular cardiac tissue was cut into small pieces approximately 2-3&#x02009;mm thick, immediately fixed in electron microscopic solution (2.5% glutaraldehyde) for 24&#x02009;hours, stained with toluidine blue for the more conspicuous areas, stained with 4% methanolic uranyl acetate and Reynolds lead citrate stain, and observed with a transmission electron microscope to observe the ultrastructure of mouse myocardial mitochondria (TM -3000; Hitachi, Ltd, Tokyo, Japan).</p></div><div id="Sec23" class="sec"><h3 id="Sec23title">Transcriptome sequencing analysis</h3><p id="Par35" class="p p-first-last">The total high-purity RNA from mouse cardiac tissue was first isolated and converted into raw sequences by base calling for quality control using software<sup><sup><a href="#CR84" rid="CR84" class=" bibr popnode">84</a></sup></sup>. Then, hisat2 software was used for comparison with the reference gene group, and valid comparison reference genes were obtained by feature count soft count gene number. The basic data after using all resources and software are shown in the table (Table&#x000a0;<sup><a href="#MOESM1" rid="MOESM1" class=" media">S1</a></sup>) below and used for data analysis and plotting. Differentially expressed genes between groups with Limma moderated t test correction (<em>P</em>&#x02009;&#x0003c;&#x02009;0.1).</p></div><div id="Sec24" class="sec"><h3 id="Sec24title">Untargeted metabolomics analysis based on HPLC-Zeno TOF-MS/MS</h3><p id="Par36" class="p p-first">In this experiment, a total of 36 samples were analyzed, consisting of six groups: TAC 8&#x02009;W+Sema, sham+Sema, TAC 8&#x02009;W, sham, TAC 8&#x02009;W+shRNA, and TAC 8&#x02009;W+shNR4a1. Each group contained six biological replicates. In addition, quality control samples were prepared by mixing nine randomly selected samples from the aforementioned 36 samples. The specific method is the mouse cardiac tissue was separated and homogenized in ultrafiltered water. Subsequently, 4 times the volume of acetonitrile-methanol solution (50% v/v) was added to the tissue homogenate, followed by ultrasonic lysis for 10&#x02009;minutes and refrigeration for 1&#x02009;hour to precipitate the protein. The supernatant was obtained by centrifugation and dried under high-purity nitrogen gas. The supernatant was reconstituted using 50% v/v acetonitrile in water and centrifuged again. The supernatants were then collected and transferred to vials, and quality control samples were made.</p><p id="Par37">The metabolites were dissolved by liquid chromatography using mobile phase A and then separated via ExionLC&#x02122; Series UHPLC. Mobile phase A was an aqueous solution containing 0.1% formic acid; mobile phase B was acetonitrile. The liquid phase gradient settings were as follows: 0&#x02013;2.0&#x02009;min, 1% B; 2.0&#x02013;12.0&#x02009;min, 1%&#x02013;99% B; 12.0&#x02013;19.0&#x02009;min, 99% B; 19.0&#x02013;19.1&#x02009;min, 99%&#x02013;1% B; and 19.1&#x02013;21.9&#x02009;min, 1% B. The flow rate was maintained at 300 nL/min. The metabolites were separated by the Kinetex&#x000ae; polar C18 reverse phase column (Strata&#x02122;-X, Phenomenex, 00D-4759-AN), and then injected into an ESI ion source for ionization and then into a SCIEX-ZenoTOF 7600 system (AB Sciex Pte. Ltd). The TOF MS experiment settings were as follows: spray voltage, 5.5&#x02009;kV; declustering potential, 60&#x02009;V; collision energy, 10&#x02009;V; and scan range, 60&#x02013;1000&#x02009;Da with an accumulation time of 0.15&#x02009;s. The TOF MS/MS settings were as follows: declustering potential, 60&#x02009;V; and collision energy, 35&#x02009;&#x000b1;&#x02009;15&#x02009;V. The secondary mass spectrometry scan ranged between 25 and 1000&#x02009;Da. The data acquisition mode was performed using the Data Independent Acquisition (IDA) program, and the zeno threshold was set at 2000000&#x02009;cps.</p><p id="Par38" class="p p-last">Metabolite identities were confirmed based on inter self-built libraries and MetDNA (<a href="http://www.metdna.zhulab.cn" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.metdna.zhulab.cn</a>). The identity process settings of inter self-built libraries were as follows: 5 ppm error tolerance in precursor ion m/z and fragment ion spectra; and less than 5% shift in retention time relative to purified standard metabolites. The relative quantification of metabolites was determined by the peak area of the precursor ion, which was normalized to total protein. Statistical analysis was performed using MetaboAnalyst 5.0 (<a href="https://www.metaboanalyst.ca" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://www.metaboanalyst.ca</a>). Graphs were generated via R and GraphPad Prism 9.4.1 (associated data was provided in Supplementary Data&#x000a0;<sup><a href="#MOESM4" rid="MOESM4" class=" media">1</a></sup>).</p></div><div id="Sec25" class="sec"><h3 id="Sec25title">Western blotting and immunoprecipitation</h3><p id="Par39" class="p p-first-last">To check the interaction relationship between Creb5 and NR4a1, proteins were extracted by lysis of NRVMs or cardiac tissue with a RIPA lysis buffer system (Santa Cruz Biotechnology, sc-24948). Protein concentrations of all samples were quantitatively and uniformly extracted with BCA. Then, they were configured in 10% SDS&#x02012;PAGE gels, and separated by electrophoresis of equal amounts of protein on the samples. Then, the proteins were transferred to PVDF membranes with a transfer solution at a specific voltage. After the proteins were blocked in 5% skim milk for one hour, they were incubated overnight with the primary target protein antibody (anti-DRP1,SANTA #SC-32898 1:1000; anti-OPA1, SANTA #sc-30573 1:1000; anti-Mfn1, SANTA #sc-50330 1:1000; anti-Mfn2, SANTA #sc-100560 1:1000; anti-Tom20, SANTA #sc-17764 1:1000; anti-COX IV, CST #11967 1:1000; anti-SDHB, ABclonal #A23832 1:2000; anti-NDUFV2, ABclonal #A7442 1:2000; anti-ATP5A1, proteintech #14676-1-AP 1:1000; anti-VDAC, ABCAM #ab191440 1:1000; anti-GLUT1, ABclonal #A11208 1:1000; anti-GLUT4, ABCAM #ab654 1:1000; anti-CD36 proteintech #18836-1-AP 1:2000; anti-&#x003b2;-Actin, CST #4970 1:1000; anti-PI3K, CST #4257 1:1000; anti-Akt, CST #4691 1:1000; anti-p-Akt (Ser473), CST #4691 1:1000; anti-NR4a1, CST #3960 1:1000; anti-Creb5, ABCAM #ab168928 1:1000; anti-P-NR4a1, CST #5095 1:1000; anti-Lamin B1, proteintech #12987-1-AP 1:1000; anti-UQCRC2, ABclonal #A4366 1:1000, anti-MTCO1, ABclonal #A17889 1:1000; anti-NDUFB8, ABclonal #A19732 1:1000). The next day, the membrane was incubated with a secondary antibody of the same species (mouse or rabbit) for one hour, and immunoblotting was detected using the Chemidoc Touch Imaging System (Bio-Rad, USA). Coimmunoprecipitation assays were carried out according to the standard method purchased from Beyotime (Shanghai, China). Protein A&#x02009;+&#x02009;G agarose electrophoresis was performed according to the instructions for the experiment. Anti-immunoglobulin G antibody and anti-Creb5 antibody were incubated together with lysates of mouse left ventricular cardiac tissue overnight at 4&#x02009;&#x000b0;C with rotation and then incubated with protein A&#x02009;+&#x02009;G agarose for 3-4&#x02009;hours at 4&#x02009;&#x000b0;C. Then, the magnetic beads were repeatedly washed 4-5 times with prechilled PBS and boiled with 1&#x000d7; SDS loading buffer. The supernatant was then subjected to western blotting to determine the interaction between Creb5 and NR4a1.</p></div><div id="Sec26" class="sec"><h3 id="Sec26title">Quantitative real-time polymerase chain reaction (qRT&#x02012;PCR)</h3><p id="Par40" class="p p-first-last">To determine mRNA expression, total RNA was extracted from each sample group using TRIzol reagent, and cDNA synthesis was performed using a Transcription First Strand cDNA Synthesis Kit (Roche, Basel, Switzerland). Then, 480 SYBR green dye was used for quantitative real-time PCR. Gene expression was determined by reverse transcription-polymerase chain reaction using a Roche LightCycler 1 detection system. RNA levels were normalized to &#x003b2;-actin levels, and changes in CT cycle values between groups were compared. The expression of the target genes in each group were compared using the 2<sup>-&#x00394;&#x00394;CT</sup> method and normalized using statistical analysis (the sequence is shown in Supplementary Data&#x000a0;<sup><a href="#MOESM5" rid="MOESM5" class=" media">2</a></sup>).</p></div><div id="Sec27" class="sec"><h3 id="Sec27title">Data analysis</h3><p id="Par41" class="p p-first-last">All data in this study are expressed as the mean&#x02009;&#x000b1;&#x02009;SEM, and statistical analysis was performed using GraphPad Prism 9.4.1 software. Guided by preliminary data analysis, comparisons between two groups with a normal distribution and homogeneity of variance were performed using an unpaired two-tailed Student&#x02032;s t test, whereas one-way analysis of variance (ANOVA) followed by Bonferroni post hoc test was conducted for comparisons among three or more groups. Analyzes with p&#x02009;&#x0003c;&#x02009;0.05 were considered statistically significant, and the corresponding p values are indicated above each legend. Related software and algorithms are listed in Table&#x000a0;<sup><a href="#MOESM1" rid="MOESM1" class=" media">S1</a></sup>. We collected data from animal studies in a blinded manner and performed the final statistical analysis.</p></div><div id="Sec28" class="sec sec-last"><h3 id="Sec28title">Reporting summary</h3><p id="Par42" class="p p-first-last">Further information on research design is available in the&#x000a0;<sup><a href="#MOESM7" rid="MOESM7" class=" media">Nature Portfolio Reporting Summary</a></sup> linked to this article.</p></div></div><div id="sec-a.t.e" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="headless nomenu"></h2><!--/article/body/sec/--><div id="Sec29" class="sec sec-first"><h3 id="Sec29title">Supplementary information</h3><p class="p p-first-last">
</p><div class="sec suppmat" id="MOESM1"><div class="sup-box half_rhythm" id="media-a.t.e.a.b.a.a"><a href="/pmc/articles/PMC11150406/bin/41467_2024_48970_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl">Supplementary Information</a><sup>(1.4M, pdf)</sup></div></div><p>
</p><div class="sec suppmat" id="MOESM2"><div class="sup-box half_rhythm" id="media-a.t.e.a.b.b.a"><a href="/pmc/articles/PMC11150406/bin/41467_2024_48970_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl">Peer Review File</a><sup>(4.7M, pdf)</sup></div></div><p>
</p><div class="sec suppmat" id="MOESM3"><div class="sup-box half_rhythm" id="media-a.t.e.a.b.c.a"><a href="/pmc/articles/PMC11150406/bin/41467_2024_48970_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl">Description of Additional Supplementary Files</a><sup>(31K, pdf)</sup></div></div><p>
</p><div class="sec suppmat" id="MOESM4"><div class="sup-box half_rhythm" id="media-a.t.e.a.b.d.a"><a href="/pmc/articles/PMC11150406/bin/41467_2024_48970_MOESM4_ESM.xlsx" data-ga-action="click_feat_suppl">Dataset1</a><sup>(357K, xlsx)</sup></div></div><p>
</p><div class="sec suppmat" id="MOESM5"><div class="sup-box half_rhythm" id="media-a.t.e.a.b.e.a"><a href="/pmc/articles/PMC11150406/bin/41467_2024_48970_MOESM5_ESM.xlsx" data-ga-action="click_feat_suppl">Dataset2</a><sup>(12K, xlsx)</sup></div></div><p>
</p><div class="sec suppmat" id="MOESM6"><div class="sup-box half_rhythm" id="media-a.t.e.a.b.f.a"><a href="/pmc/articles/PMC11150406/bin/41467_2024_48970_MOESM6_ESM.xlsx" data-ga-action="click_feat_suppl">Dataset 3</a><sup>(1.0M, xlsx)</sup></div></div><p>
</p><div class="sec suppmat" id="MOESM7"><div class="sup-box half_rhythm" id="media-a.t.e.a.b.g.a"><a href="/pmc/articles/PMC11150406/bin/41467_2024_48970_MOESM7_ESM.pdf" data-ga-action="click_feat_suppl">Reporting Summary</a><sup>(110K, pdf)</sup></div></div><p>
</p></div><div id="Sec30" class="sec sec-last"><h3 id="Sec30title">Source data</h3><p class="p p-first-last">
</p><div class="sec suppmat" id="MOESM8"><div class="sup-box half_rhythm" id="media-a.t.e.b.b.a.a"><a href="/pmc/articles/PMC11150406/bin/41467_2024_48970_MOESM8_ESM.xlsx" data-ga-action="click_feat_suppl">source data</a><sup>(666K, xlsx)</sup></div></div><p>
</p></div></div><div id="ack-a.u.c" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.u.ctitle">Acknowledgements</h2><div class="sec"><p>This work was supported by grants from The Regional Innovation and Development Joint Fund of National Natural Science Foundation of China (No. U22A20269) (QZ.T), National Key R&#x00026;D Program of China (2018YFC1311300) (QZ.T), The National Natural Science Foundation of China (81530012) (QZ.T) and The Fundamental Research Funds for the Central Universities(2042023kf0016) (CY.K).</p></div></div><div id="notes-a.u.d" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.u.dtitle">Author contributions</h2><p>QZ.T, YL.M, CY.K., and Z.G. supervised and conceptualized the study. YL.M., CY.K., and Z.G. designed and performed the majority of the experiments and analyzed the majority of the data. YL.M., CY.K., and Z.G. wrote and edited the manuscript. MY.W., P.W., D.Y.I., FY.L., and Z.Y. assisted with some experiments and discussed the results. All authors edited and approved the manuscript.</p></div><div id="notes-a.u.e" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.u.etitle">Peer review</h2><div id="FPar1" class="sec sec-first"><h2 id="FPar1title">Peer review information</h2><p id="Par43" class="p p-first-last"><em>Nature Communications</em> thanks Stephen Safe, Gaurav Sharma and the other, anonymous, reviewer for their contribution to the peer review of this work. A peer review file is available.</p></div></div><div id="notes-a.u.f" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.u.ftitle">Data availability</h2><p>The data supporting the findings from this study are available within the manuscript and its&#x000a0;<sup><a href="#MOESM1" rid="MOESM1" class=" media">supplementary information</a></sup>. Source data are provided with this paper. Any additional raw data are available from the corresponding author upon reasonable request. The datasets generated for the RNA-seq are available through the Gene Expression Omnibus under accession code <a id="__tag_1150184227" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE262105" ref="/geo/query/acc.cgi?acc=GSE262105"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE262105","term_id":"262105"}}</span>GSE262105</a>. The Metabolomic data generated in this study have been deposited in MassIVE under accession code ID: <a href="ftp://massive.ucsd.edu/v07/MSV000094408/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">MSV000094408</a>.&#x000a0;<a href="#Sec30" rid="Sec30" class=" sec">Source data</a> are provided with this paper.</p></div><div id="FPar2" class="tsec sec"><h2 class="head no_bottom_margin" id="FPar2title">Competing interests</h2><p id="Par44">The authors declare no competing interests.</p></div><div id="fn-group-a.u.a" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.u.atitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="fn-a.u.a.a"><p class="p p-first-last"><strong>Publisher&#x02019;s note</strong> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></p><p class="fn sec" id="fn-a.u.a.b"><p class="p p-first-last">These authors contributed equally: Yu-Lan Ma, Chun-Yan Kong, Zhen Guo.</p></p></div></div><div id="sec-a.u.b" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="sec-a.u.btitle">Supplementary information</h2><!--/article/back/sec/--><p class="p p-first-last">The online version contains supplementary material available at 10.1038/s41467-024-48970-2.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling&#x02013;concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling. <span><span class="ref-journal">J. Am. Coll. Cardiol. </span>2000;<span class="ref-vol">35</span>:569–582. doi: 10.1016/S0735-1097(99)00630-0.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10716457" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0735-1097(99)00630-0" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Am.+Coll.+Cardiol.&amp;title=Cardiac+remodeling&#x02013;concepts+and+clinical+implications:+a+consensus+paper+from+an+international+forum+on+cardiac+remodeling.+Behalf+of+an+international+forum+on+cardiac+remodeling&amp;author=JN+Cohn&amp;author=R+Ferrari&amp;author=N+Sharpe&amp;volume=35&amp;publication_year=2000&amp;pages=569-582&amp;pmid=10716457&amp;doi=10.1016/S0735-1097(99)00630-0&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Bertero E, Maack C. Metabolic remodelling in heart failure. <span><span class="ref-journal">Nat. Rev. Cardiol. </span>2018;<span class="ref-vol">15</span>:457–470. doi: 10.1038/s41569-018-0044-6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29915254" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41569-018-0044-6" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Cardiol.&amp;title=Metabolic+remodelling+in+heart+failure&amp;author=E+Bertero&amp;author=C+Maack&amp;volume=15&amp;publication_year=2018&amp;pages=457-470&amp;pmid=29915254&amp;doi=10.1038/s41569-018-0044-6&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Saddik M, Lopaschuk GD. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. <span><span class="ref-journal">J. Biol. Chem. </span>1991;<span class="ref-vol">266</span>:8162–8170. doi: 10.1016/S0021-9258(18)92956-X.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1902472" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0021-9258(18)92956-X" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Biol.+Chem.&amp;title=Myocardial+triglyceride+turnover+and+contribution+to+energy+substrate+utilization+in+isolated+working+rat+hearts&amp;author=M+Saddik&amp;author=GD+Lopaschuk&amp;volume=266&amp;publication_year=1991&amp;pages=8162-8170&amp;pmid=1902472&amp;doi=10.1016/S0021-9258(18)92956-X&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Wende AR, et al. Glucose transporter 4-deficient hearts develop maladaptive hypertrophy in response to physiological or pathological stresses. <span><span class="ref-journal">Am. J. Physiol. Heart circulatory Physiol. </span>2017;<span class="ref-vol">313</span>:H1098–h1108. doi: 10.1152/ajpheart.00101.2017.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5814656/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28822962" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1152%2Fajpheart.00101.2017" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J.+Physiol.+Heart+circulatory+Physiol.&amp;title=Glucose+transporter+4-deficient+hearts+develop+maladaptive+hypertrophy+in+response+to+physiological+or+pathological+stresses&amp;author=AR+Wende&amp;volume=313&amp;publication_year=2017&amp;pages=H1098-h1108&amp;doi=10.1152/ajpheart.00101.2017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Sankaralingam S, et al. Lowering body weight in obese mice with diastolic heart failure improves cardiac insulin sensitivity and function: implications for the obesity paradox. <span><span class="ref-journal">Diabetes. </span>2015;<span class="ref-vol">64</span>:1643–1657. doi: 10.2337/db14-1050.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25524917" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.2337%2Fdb14-1050" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Lowering+body+weight+in+obese+mice+with+diastolic+heart+failure+improves+cardiac+insulin+sensitivity+and+function:+implications+for+the+obesity+paradox&amp;author=S+Sankaralingam&amp;volume=64&amp;publication_year=2015&amp;pages=1643-1657&amp;pmid=25524917&amp;doi=10.2337/db14-1050&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="mixed-citation">Fernandez-Caggiano, M. et al. Heart failure-emerging roles for the mitochondrial pyruvate carrier. <em>Cell Death Differ</em>. <strong>4</strong>, 1149&#x02013;1158 (2021). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8027425/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33473180" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Fernandez-Caggiano M, et al. Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy. <span><span class="ref-journal">Nat. Metab. </span>2020;<span class="ref-vol">2</span>:1223–1231. doi: 10.1038/s42255-020-00276-5.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7610404/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33106688" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs42255-020-00276-5" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Metab.&amp;title=Mitochondrial+pyruvate+carrier+abundance+mediates+pathological+cardiac+hypertrophy&amp;author=M+Fernandez-Caggiano&amp;volume=2&amp;publication_year=2020&amp;pages=1223-1231&amp;pmid=33106688&amp;doi=10.1038/s42255-020-00276-5&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Keceli G, et al. Mitochondrial creatine kinase attenuates pathologic remodeling in heart failure. <span><span class="ref-journal">Circulation Res. </span>2022;<span class="ref-vol">130</span>:741–759.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8897235/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35109669" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation+Res.&amp;title=Mitochondrial+creatine+kinase+attenuates+pathologic+remodeling+in+heart+failure&amp;author=G+Keceli&amp;volume=130&amp;publication_year=2022&amp;pages=741-759&amp;pmid=35109669&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Ranjbarvaziri S, et al. Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy. <span><span class="ref-journal">Circulation. </span>2021;<span class="ref-vol">144</span>:1714–1731. doi: 10.1161/CIRCULATIONAHA.121.053575.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8608736/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34672721" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1161%2FCIRCULATIONAHA.121.053575" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Altered+cardiac+energetics+and+mitochondrial+dysfunction+in+hypertrophic+cardiomyopathy&amp;author=S+Ranjbarvaziri&amp;volume=144&amp;publication_year=2021&amp;pages=1714-1731&amp;pmid=34672721&amp;doi=10.1161/CIRCULATIONAHA.121.053575&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Lydell CP, et al. Pyruvate dehydrogenase and the regulation of glucose oxidation in hypertrophied rat hearts. <span><span class="ref-journal">Cardiovascular Res. </span>2002;<span class="ref-vol">53</span>:841–851. doi: 10.1016/S0008-6363(01)00560-0.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2131743/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11922894" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0008-6363(01)00560-0" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular+Res.&amp;title=Pyruvate+dehydrogenase+and+the+regulation+of+glucose+oxidation+in+hypertrophied+rat+hearts&amp;author=CP+Lydell&amp;volume=53&amp;publication_year=2002&amp;pages=841-851&amp;doi=10.1016/S0008-6363(01)00560-0&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Wang L, et al. Digenic variants of planar cell polarity genes in human neural tube defect patients. <span><span class="ref-journal">Mol. Genet. Metab. </span>2018;<span class="ref-vol">124</span>:94–100. doi: 10.1016/j.ymgme.2018.03.005.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5966321/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29573971" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.ymgme.2018.03.005" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Genet.+Metab.&amp;title=Digenic+variants+of+planar+cell+polarity+genes+in+human+neural+tube+defect+patients&amp;author=L+Wang&amp;volume=124&amp;publication_year=2018&amp;pages=94-100&amp;pmid=29573971&amp;doi=10.1016/j.ymgme.2018.03.005&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Butler J, et al. Effects of elamipretide on left ventricular function in patients with heart failure with reduced ejection fraction: The PROGRESS-HF Phase 2 Trial. <span><span class="ref-journal">J. Card. Fail. </span>2020;<span class="ref-vol">26</span>:429–437. doi: 10.1016/j.cardfail.2020.02.001.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32068002" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.cardfail.2020.02.001" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Card.+Fail.&amp;title=Effects+of+elamipretide+on+left+ventricular+function+in+patients+with+heart+failure+with+reduced+ejection+fraction:+The+PROGRESS-HF+Phase+2+Trial&amp;author=J+Butler&amp;volume=26&amp;publication_year=2020&amp;pages=429-437&amp;pmid=32068002&amp;doi=10.1016/j.cardfail.2020.02.001&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Ritterhoff J, Tian R. Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges. <span><span class="ref-journal">Nat. Rev. Cardiol. </span>2023;<span class="ref-vol">20</span>:812–829. doi: 10.1038/s41569-023-00887-x.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37237146" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41569-023-00887-x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Cardiol.&amp;title=Metabolic+mechanisms+in+physiological+and+pathological+cardiac+hypertrophy:+new+paradigms+and+challenges&amp;author=J+Ritterhoff&amp;author=R+Tian&amp;volume=20&amp;publication_year=2023&amp;pages=812-829&amp;pmid=37237146&amp;doi=10.1038/s41569-023-00887-x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Kosiborod MN, Borlaug BA, Petrie MC. Semaglutide and heart failure with preserved ejection fraction and obesity. reply. <span><span class="ref-journal">N. Engl. J. Med. </span>2023;<span class="ref-vol">389</span>:2398–2399. doi: 10.1056/NEJMoa2306963.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/38118037" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1056%2FNEJMoa2306963" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N.+Engl.+J.+Med.&amp;title=Semaglutide+and+heart+failure+with+preserved+ejection+fraction+and+obesity.+reply&amp;author=MN+Kosiborod&amp;author=BA+Borlaug&amp;author=MC+Petrie&amp;volume=389&amp;publication_year=2023&amp;pages=2398-2399&amp;pmid=38118037&amp;doi=10.1056/NEJMoa2306963&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Honigberg MC, et al. Use of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and cardiovascular disease: a review. <span><span class="ref-journal">JAMA Cardiol. </span>2020;<span class="ref-vol">5</span>:1182–1190. doi: 10.1001/jamacardio.2020.1966.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7744318/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32584928" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1001%2Fjamacardio.2020.1966" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA+Cardiol.&amp;title=Use+of+glucagon-like+peptide-1+receptor+agonists+in+patients+with+type+2+diabetes+and+cardiovascular+disease:+a+review&amp;author=MC+Honigberg&amp;volume=5&amp;publication_year=2020&amp;pages=1182-1190&amp;pmid=32584928&amp;doi=10.1001/jamacardio.2020.1966&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Westerink J, et al. Estimated life-years gained free of new or recurrent major cardiovascular events with the addition of semaglutide to standard of care in people with type 2 diabetes and high cardiovascular risk. <span><span class="ref-journal">Diabetes Care. </span>2022;<span class="ref-vol">45</span>:1211–1218. doi: 10.2337/dc21-1138.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9174968/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35263432" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.2337%2Fdc21-1138" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes+Care&amp;title=Estimated+life-years+gained+free+of+new+or+recurrent+major+cardiovascular+events+with+the+addition+of+semaglutide+to+standard+of+care+in+people+with+type+2+diabetes+and+high+cardiovascular+risk&amp;author=J+Westerink&amp;volume=45&amp;publication_year=2022&amp;pages=1211-1218&amp;pmid=35263432&amp;doi=10.2337/dc21-1138&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Weghuber D, Kelly AS, Arslanian S. Once-weekly semaglutide in adolescents with obesity. reply. <span><span class="ref-journal">N. Engl. J. Med. </span>2023;<span class="ref-vol">388</span>:1146.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36947476" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N.+Engl.+J.+Med.&amp;title=Once-weekly+semaglutide+in+adolescents+with+obesity.+reply&amp;author=D+Weghuber&amp;author=AS+Kelly&amp;author=S+Arslanian&amp;volume=388&amp;publication_year=2023&amp;pages=1146&amp;pmid=36947476&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Horowitz M, et al. Response to Dahl et al.: Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes. <span><span class="ref-journal">Diabetes Obes. Metab. </span>2021;<span class="ref-vol">23</span>:2411–2413. doi: 10.1111/dom.14473.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34169640" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fdom.14473" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes+Obes.+Metab.&amp;title=Response+to+Dahl+et+al.:+Oral+semaglutide+improves+postprandial+glucose+and+lipid+metabolism,+and+delays+gastric+emptying,+in+subjects+with+type+2+diabetes&amp;author=M+Horowitz&amp;volume=23&amp;publication_year=2021&amp;pages=2411-2413&amp;pmid=34169640&amp;doi=10.1111/dom.14473&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Zhu R, Chen S. Proteomic analysis reveals semaglutide impacts lipogenic protein expression in epididymal adipose tissue of obese mice. <span><span class="ref-journal">Front. Endocrinol. </span>2023;<span class="ref-vol">14</span>:1095432. doi: 10.3389/fendo.2023.1095432.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10070826/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37025414" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffendo.2023.1095432" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front.+Endocrinol.&amp;title=Proteomic+analysis+reveals+semaglutide+impacts+lipogenic+protein+expression+in+epididymal+adipose+tissue+of+obese+mice&amp;author=R+Zhu&amp;author=S+Chen&amp;volume=14&amp;publication_year=2023&amp;pages=1095432&amp;doi=10.3389/fendo.2023.1095432&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Vinayavekhin N, Saghatelian A. Discovery of a protein-metabolite interaction between unsaturated fatty acids and the nuclear receptor Nur77 using a metabolomics approach. <span><span class="ref-journal">J. Am. Chem. Soc. </span>2011;<span class="ref-vol">133</span>:17168–17171. doi: 10.1021/ja208199h.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4569094/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21973308" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1021%2Fja208199h" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Am.+Chem.+Soc.&amp;title=Discovery+of+a+protein-metabolite+interaction+between+unsaturated+fatty+acids+and+the+nuclear+receptor+Nur77+using+a+metabolomics+approach&amp;author=N+Vinayavekhin&amp;author=A+Saghatelian&amp;volume=133&amp;publication_year=2011&amp;pages=17168-17171&amp;pmid=21973308&amp;doi=10.1021/ja208199h&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Zhao Y, Bruemmer D. NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology. <span><span class="ref-journal">Arteriosclerosis, thrombosis, Vasc. Biol. </span>2010;<span class="ref-vol">30</span>:1535–1541. doi: 10.1161/ATVBAHA.109.191163.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2907171/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20631354" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1161%2FATVBAHA.109.191163" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arteriosclerosis,+thrombosis,+Vasc.+Biol.&amp;title=NR4A+orphan+nuclear+receptors:+transcriptional+regulators+of+gene+expression+in+metabolism+and+vascular+biology&amp;author=Y+Zhao&amp;author=D+Bruemmer&amp;volume=30&amp;publication_year=2010&amp;pages=1535-1541&amp;doi=10.1161/ATVBAHA.109.191163&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Yang PB, et al. Blocking PPAR&#x003b3; interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression. <span><span class="ref-journal">Proc. Natl Acad. Sci. USA. </span>2020;<span class="ref-vol">117</span>:27412–27422. doi: 10.1073/pnas.2002997117.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7959534/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33087562" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1073%2Fpnas.2002997117" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl+Acad.+Sci.+USA&amp;title=Blocking+PPAR&#x003b3;+interaction+facilitates+Nur77+interdiction+of+fatty+acid+uptake+and+suppresses+breast+cancer+progression&amp;author=PB+Yang&amp;volume=117&amp;publication_year=2020&amp;pages=27412-27422&amp;pmid=33087562&amp;doi=10.1073/pnas.2002997117&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">He L, et al. A regulation loop between YAP and NR4A1 balances cell proliferation and apoptosis. <span><span class="ref-journal">Cell Rep. </span>2020;<span class="ref-vol">33</span>:108284. doi: 10.1016/j.celrep.2020.108284.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33086070" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.celrep.2020.108284" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Rep.&amp;title=A+regulation+loop+between+YAP+and+NR4A1+balances+cell+proliferation+and+apoptosis&amp;author=L+He&amp;volume=33&amp;publication_year=2020&amp;pages=108284&amp;pmid=33086070&amp;doi=10.1016/j.celrep.2020.108284&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Weghuber D, et al. Once-weekly semaglutide in adolescents with obesity. <span><span class="ref-journal">N. Engl. J. Med. </span>2022;<span class="ref-vol">387</span>:2245–2257. doi: 10.1056/NEJMoa2208601.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9997064/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36322838" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1056%2FNEJMoa2208601" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N.+Engl.+J.+Med.&amp;title=Once-weekly+semaglutide+in+adolescents+with+obesity&amp;author=D+Weghuber&amp;volume=387&amp;publication_year=2022&amp;pages=2245-2257&amp;pmid=36322838&amp;doi=10.1056/NEJMoa2208601&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Umbarkar P, et al. Fibroblast GSK-3&#x003b1; promotes fibrosis via RAF-MEK-ERK pathway in the injured heart. <span><span class="ref-journal">Circulation Res. </span>2022;<span class="ref-vol">131</span>:620–636. doi: 10.1161/CIRCRESAHA.122.321431.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9481711/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36052698" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1161%2FCIRCRESAHA.122.321431" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation+Res.&amp;title=Fibroblast+GSK-3&#x003b1;+promotes+fibrosis+via+RAF-MEK-ERK+pathway+in+the+injured+heart&amp;author=P+Umbarkar&amp;volume=131&amp;publication_year=2022&amp;pages=620-636&amp;pmid=36052698&amp;doi=10.1161/CIRCRESAHA.122.321431&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Kuhn AR, van Bilsen M. Oncometabolism: a paradigm for the metabolic remodeling of the failing heart. <span><span class="ref-journal">Int. J. Mol. Sci. </span>2022;<span class="ref-vol">23</span>:13902. doi: 10.3390/ijms232213902.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9699042/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36430377" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fijms232213902" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Mol.+Sci.&amp;title=Oncometabolism:+a+paradigm+for+the+metabolic+remodeling+of+the+failing+heart&amp;author=AR+Kuhn&amp;author=M+van+Bilsen&amp;volume=23&amp;publication_year=2022&amp;pages=13902&amp;pmid=36430377&amp;doi=10.3390/ijms232213902&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="mixed-citation">He, X. et al. p53 Acetylation Exerts Critical Roles in Pressure Overload-Induced Coronary Microvascular Dysfunction and Heart Failure in Mice. <em>Arteriosclerosis, thrombosis, and vascular biology</em>, (2024). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10978286/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/38328937" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Nollet EE, et al. Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration. <span><span class="ref-journal">Eur. heart J. </span>2023;<span class="ref-vol">44</span>:1170–1185. doi: 10.1093/eurheartj/ehad028.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10067466/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36734059" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Feurheartj%2Fehad028" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur.+heart+J.&amp;title=Mitochondrial+dysfunction+in+human+hypertrophic+cardiomyopathy+is+linked+to+cardiomyocyte+architecture+disruption+and+corrected+by+improving+NADH-driven+mitochondrial+respiration&amp;author=EE+Nollet&amp;volume=44&amp;publication_year=2023&amp;pages=1170-1185&amp;pmid=36734059&amp;doi=10.1093/eurheartj/ehad028&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Vercellino I, Sazanov LA. The assembly, regulation and function of the mitochondrial respiratory chain. <span><span class="ref-journal">Nat. Rev. Mol. Cell Biol. </span>2022;<span class="ref-vol">23</span>:141–161. doi: 10.1038/s41580-021-00415-0.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34621061" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41580-021-00415-0" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Mol.+Cell+Biol.&amp;title=The+assembly,+regulation+and+function+of+the+mitochondrial+respiratory+chain&amp;author=I+Vercellino&amp;author=LA+Sazanov&amp;volume=23&amp;publication_year=2022&amp;pages=141-161&amp;pmid=34621061&amp;doi=10.1038/s41580-021-00415-0&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">Watson WD, et al. Retained metabolic flexibility of the failing human heart. <span><span class="ref-journal">Circulation. </span>2023;<span class="ref-vol">148</span>:109–123. doi: 10.1161/CIRCULATIONAHA.122.062166.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10417210/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37199155" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1161%2FCIRCULATIONAHA.122.062166" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Retained+metabolic+flexibility+of+the+failing+human+heart&amp;author=WD+Watson&amp;volume=148&amp;publication_year=2023&amp;pages=109-123&amp;pmid=37199155&amp;doi=10.1161/CIRCULATIONAHA.122.062166&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Umbarawan Y, et al. Glucose is preferentially utilized for biomass synthesis in pressure-overloaded hearts: evidence from fatty acid-binding protein-4 and -5 knockout mice. <span><span class="ref-journal">Cardiovascular Res. </span>2018;<span class="ref-vol">114</span>:1132–1144. doi: 10.1093/cvr/cvy063.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6014234/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29554241" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Fcvr%2Fcvy063" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular+Res.&amp;title=Glucose+is+preferentially+utilized+for+biomass+synthesis+in+pressure-overloaded+hearts:+evidence+from+fatty+acid-binding+protein-4+and+-5+knockout+mice&amp;author=Y+Umbarawan&amp;volume=114&amp;publication_year=2018&amp;pages=1132-1144&amp;doi=10.1093/cvr/cvy063&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">He W, et al. Molecular mechanism of naringenin against high-glucose-induced vascular smooth muscle cells proliferation and migration based on network pharmacology and transcriptomic analyses. <span><span class="ref-journal">Front. Pharmacol. </span>2022;<span class="ref-vol">13</span>:862709. doi: 10.3389/fphar.2022.862709.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9219407/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35754483" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffphar.2022.862709" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front.+Pharmacol.&amp;title=Molecular+mechanism+of+naringenin+against+high-glucose-induced+vascular+smooth+muscle+cells+proliferation+and+migration+based+on+network+pharmacology+and+transcriptomic+analyses&amp;author=W+He&amp;volume=13&amp;publication_year=2022&amp;pages=862709&amp;pmid=35754483&amp;doi=10.3389/fphar.2022.862709&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Ma J, et al. O-GlcNAcomic profiling identifies widespread o-linked &#x003b2;-n-acetylglucosamine modification (o-glcnacylation) in oxidative phosphorylation system regulating cardiac mitochondrial function. <span><span class="ref-journal">J. Biol. Chem. </span>2015;<span class="ref-vol">290</span>:29141–29153. doi: 10.1074/jbc.M115.691741.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4705920/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26446791" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M115.691741" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Biol.+Chem.&amp;title=O-GlcNAcomic+profiling+identifies+widespread+o-linked+&#x003b2;-n-acetylglucosamine+modification+(o-glcnacylation)+in+oxidative+phosphorylation+system+regulating+cardiac+mitochondrial+function&amp;author=J+Ma&amp;volume=290&amp;publication_year=2015&amp;pages=29141-29153&amp;pmid=26446791&amp;doi=10.1074/jbc.M115.691741&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Wu X, et al. NDP-MSH binding melanocortin-1 receptor ameliorates neuroinflammation and BBB disruption through CREB/Nr4a1/NF-&#x003ba;B pathway after intracerebral hemorrhage in mice. <span><span class="ref-journal">J. neuroinflammation. </span>2019;<span class="ref-vol">16</span>:192. doi: 10.1186/s12974-019-1591-4.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6816206/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31660977" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2Fs12974-019-1591-4" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+neuroinflammation&amp;title=NDP-MSH+binding+melanocortin-1+receptor+ameliorates+neuroinflammation+and+BBB+disruption+through+CREB/Nr4a1/NF-&#x003ba;B+pathway+after+intracerebral+hemorrhage+in+mice&amp;author=X+Wu&amp;volume=16&amp;publication_year=2019&amp;pages=192&amp;pmid=31660977&amp;doi=10.1186/s12974-019-1591-4&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="element-citation">Li W, et al. A bacterial bile acid metabolite modulates T(reg) activity through the nuclear hormone receptor NR4A1. <span><span class="ref-journal">Cell Host Microbe. </span>2021;<span class="ref-vol">29</span>:1366–1377.e1369. doi: 10.1016/j.chom.2021.07.013.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9064000/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34416161" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.chom.2021.07.013" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Host+Microbe&amp;title=A+bacterial+bile+acid+metabolite+modulates+T(reg)+activity+through+the+nuclear+hormone+receptor+NR4A1&amp;author=W+Li&amp;volume=29&amp;publication_year=2021&amp;pages=1366-1377.e1369&amp;pmid=34416161&amp;doi=10.1016/j.chom.2021.07.013&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="element-citation">Zhou H, et al. NR4A1 aggravates the cardiac microvascular ischemia reperfusion injury through suppressing FUNDC1-mediated mitophagy and promoting Mff-required mitochondrial fission by CK2&#x003b1; <span><span class="ref-journal">Basic Res. Cardiol. </span>2018;<span class="ref-vol">113</span>:23. doi: 10.1007/s00395-018-0682-1.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29744594" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00395-018-0682-1" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Basic+Res.+Cardiol.&amp;title=NR4A1+aggravates+the+cardiac+microvascular+ischemia+reperfusion+injury+through+suppressing+FUNDC1-mediated+mitophagy+and+promoting+Mff-required+mitochondrial+fission+by+CK2&#x003b1;&amp;author=H+Zhou&amp;volume=113&amp;publication_year=2018&amp;pages=23&amp;pmid=29744594&amp;doi=10.1007/s00395-018-0682-1&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="element-citation">He JY, et al. Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity. <span><span class="ref-journal">Acta pharmacologica Sin. </span>2022;<span class="ref-vol">43</span>:342–353. doi: 10.1038/s41401-021-00788-0.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8791932/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34811512" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41401-021-00788-0" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+pharmacologica+Sin.&amp;title=Ginsenoside+Rb1+alleviates+diabetic+kidney+podocyte+injury+by+inhibiting+aldose+reductase+activity&amp;author=JY+He&amp;volume=43&amp;publication_year=2022&amp;pages=342-353&amp;doi=10.1038/s41401-021-00788-0&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR38">38. <span class="element-citation">Hahn VS, et al. Myocardial metabolomics of human heart failure with preserved ejection fraction. <span><span class="ref-journal">Circulation. </span>2023;<span class="ref-vol">147</span>:1147–1161. doi: 10.1161/CIRCULATIONAHA.122.061846.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC11059242/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36856044" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1161%2FCIRCULATIONAHA.122.061846" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Myocardial+metabolomics+of+human+heart+failure+with+preserved+ejection+fraction&amp;author=VS+Hahn&amp;volume=147&amp;publication_year=2023&amp;pages=1147-1161&amp;pmid=36856044&amp;doi=10.1161/CIRCULATIONAHA.122.061846&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR39">39. <span class="element-citation">Cluntun AA, et al. The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. <span><span class="ref-journal">Cell Metab. </span>2021;<span class="ref-vol">33</span>:629–648.e610. doi: 10.1016/j.cmet.2020.12.003.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7933116/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33333007" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.cmet.2020.12.003" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab.&amp;title=The+pyruvate-lactate+axis+modulates+cardiac+hypertrophy+and+heart+failure&amp;author=AA+Cluntun&amp;volume=33&amp;publication_year=2021&amp;pages=629-648.e610&amp;pmid=33333007&amp;doi=10.1016/j.cmet.2020.12.003&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR40">40. <span class="element-citation">van Bilsen M. &#x0201c;Energenetics&#x0201d; of heart failure. <span><span class="ref-journal">Ann. N. Y Acad. Sci. </span>2004;<span class="ref-vol">1015</span>:238–249. doi: 10.1196/annals.1302.020.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15201164" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1196%2Fannals.1302.020" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann.+N.+Y+Acad.+Sci.&amp;title=&#x0201c;Energenetics&#x0201d;+of+heart+failure&amp;author=M+van+Bilsen&amp;volume=1015&amp;publication_year=2004&amp;pages=238-249&amp;pmid=15201164&amp;doi=10.1196/annals.1302.020&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR41">41. <span class="element-citation">Packer M. Role of deranged energy deprivation signaling in the pathogenesis of cardiac and renal disease in states of perceived nutrient overabundance. <span><span class="ref-journal">Circulation. </span>2020;<span class="ref-vol">141</span>:2095–2105. doi: 10.1161/CIRCULATIONAHA.119.045561.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32164457" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1161%2FCIRCULATIONAHA.119.045561" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Role+of+deranged+energy+deprivation+signaling+in+the+pathogenesis+of+cardiac+and+renal+disease+in+states+of+perceived+nutrient+overabundance&amp;author=M+Packer&amp;volume=141&amp;publication_year=2020&amp;pages=2095-2105&amp;pmid=32164457&amp;doi=10.1161/CIRCULATIONAHA.119.045561&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR42">42. <span class="element-citation">Chen Y, et al. The lncRNA Malat1 regulates microvascular function after myocardial infarction in mice via miR-26b-5p/Mfn1 axis-mediated mitochondrial dynamics. <span><span class="ref-journal">Redox Biol. </span>2021;<span class="ref-vol">41</span>:101910. doi: 10.1016/j.redox.2021.101910.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7937833/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33667993" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.redox.2021.101910" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Redox+Biol.&amp;title=The+lncRNA+Malat1+regulates+microvascular+function+after+myocardial+infarction+in+mice+via+miR-26b-5p/Mfn1+axis-mediated+mitochondrial+dynamics&amp;author=Y+Chen&amp;volume=41&amp;publication_year=2021&amp;pages=101910&amp;pmid=33667993&amp;doi=10.1016/j.redox.2021.101910&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR43">43. <span class="element-citation">Feng X, et al. Mst1 knockout alleviates mitochondrial fission and mitigates left ventricular remodeling in the development of diabetic cardiomyopathy. <span><span class="ref-journal">Front. cell developmental Biol. </span>2020;<span class="ref-vol">8</span>:628842. doi: 10.3389/fcell.2020.628842.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7859113/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33553168" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffcell.2020.628842" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front.+cell+developmental+Biol.&amp;title=Mst1+knockout+alleviates+mitochondrial+fission+and+mitigates+left+ventricular+remodeling+in+the+development+of+diabetic+cardiomyopathy&amp;author=X+Feng&amp;volume=8&amp;publication_year=2020&amp;pages=628842&amp;doi=10.3389/fcell.2020.628842&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR44">44. <span class="element-citation">Cividini F, et al. O-GlcNAcylation of 8-Oxoguanine DNA glycosylase (ogg1) impairs oxidative mitochondrial DNA lesion repair in diabetic hearts. <span><span class="ref-journal">J. Biol. Chem. </span>2016;<span class="ref-vol">291</span>:26515–26528. doi: 10.1074/jbc.M116.754481.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5159511/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27816939" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M116.754481" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Biol.+Chem.&amp;title=O-GlcNAcylation+of+8-Oxoguanine+DNA+glycosylase+(ogg1)+impairs+oxidative+mitochondrial+DNA+lesion+repair+in+diabetic+hearts&amp;author=F+Cividini&amp;volume=291&amp;publication_year=2016&amp;pages=26515-26528&amp;pmid=27816939&amp;doi=10.1074/jbc.M116.754481&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR45">45. <span class="element-citation">Fan M, et al. Lactate promotes endothelial-to-mesenchymal transition via Snail1 lactylation after myocardial infarction. <span><span class="ref-journal">Sci. Adv. </span>2023;<span class="ref-vol">9</span>:eadc9465. doi: 10.1126/sciadv.adc9465.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9897666/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36735787" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1126%2Fsciadv.adc9465" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci.+Adv.&amp;title=Lactate+promotes+endothelial-to-mesenchymal+transition+via+Snail1+lactylation+after+myocardial+infarction&amp;author=M+Fan&amp;volume=9&amp;publication_year=2023&amp;pages=eadc9465&amp;pmid=36735787&amp;doi=10.1126/sciadv.adc9465&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR46">46. <span class="element-citation">Kim JK, et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. <span><span class="ref-journal">J. Clin. Investig. </span>2004;<span class="ref-vol">114</span>:823–827. doi: 10.1172/JCI200422230.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC516267/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15372106" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1172%2FJCI200422230" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Clin.+Investig.&amp;title=PKC-theta+knockout+mice+are+protected+from+fat-induced+insulin+resistance&amp;author=JK+Kim&amp;volume=114&amp;publication_year=2004&amp;pages=823-827&amp;pmid=15372106&amp;doi=10.1172/JCI200422230&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR47">47. <span class="element-citation">Wende AR, et al. Maintaining myocardial glucose utilization in diabetic cardiomyopathy accelerates mitochondrial dysfunction. <span><span class="ref-journal">Diabetes. </span>2020;<span class="ref-vol">69</span>:2094–2111. doi: 10.2337/db19-1057.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7506832/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32366681" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.2337%2Fdb19-1057" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Maintaining+myocardial+glucose+utilization+in+diabetic+cardiomyopathy+accelerates+mitochondrial+dysfunction&amp;author=AR+Wende&amp;volume=69&amp;publication_year=2020&amp;pages=2094-2111&amp;pmid=32366681&amp;doi=10.2337/db19-1057&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR48">48. <span class="element-citation">Johnsen VL, et al. Enhanced cardiac protein glycosylation (O-GlcNAc) of selected mitochondrial proteins in rats artificially selected for low running capacity. <span><span class="ref-journal">Physiol. Genomics. </span>2013;<span class="ref-vol">45</span>:17–25. doi: 10.1152/physiolgenomics.00111.2012.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3544485/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23132757" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1152%2Fphysiolgenomics.00111.2012" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Physiol.+Genomics&amp;title=Enhanced+cardiac+protein+glycosylation+(O-GlcNAc)+of+selected+mitochondrial+proteins+in+rats+artificially+selected+for+low+running+capacity&amp;author=VL+Johnsen&amp;volume=45&amp;publication_year=2013&amp;pages=17-25&amp;pmid=23132757&amp;doi=10.1152/physiolgenomics.00111.2012&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR49">49. <span class="element-citation">Umapathi P, et al. Excessive O-GlcNacylation causes heart failure and sudden death. <span><span class="ref-journal">Circulation. </span>2021;<span class="ref-vol">143</span>:1687–1703. doi: 10.1161/CIRCULATIONAHA.120.051911.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8085112/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33593071" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1161%2FCIRCULATIONAHA.120.051911" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Excessive+O-GlcNacylation+causes+heart+failure+and+sudden+death&amp;author=P+Umapathi&amp;volume=143&amp;publication_year=2021&amp;pages=1687-1703&amp;pmid=33593071&amp;doi=10.1161/CIRCULATIONAHA.120.051911&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR50">50. <span class="element-citation">Jun M, et al. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. <span><span class="ref-journal">Lancet. </span>2010;<span class="ref-vol">375</span>:1875–1884. doi: 10.1016/S0140-6736(10)60656-3.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20462635" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0140-6736(10)60656-3" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Effects+of+fibrates+on+cardiovascular+outcomes:+a+systematic+review+and+meta-analysis&amp;author=M+Jun&amp;volume=375&amp;publication_year=2010&amp;pages=1875-1884&amp;pmid=20462635&amp;doi=10.1016/S0140-6736(10)60656-3&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR51">51. <span class="element-citation">Tuunanen H, et al. Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. <span><span class="ref-journal">Circulation. </span>2006;<span class="ref-vol">114</span>:2130–2137. doi: 10.1161/CIRCULATIONAHA.106.645184.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17088453" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1161%2FCIRCULATIONAHA.106.645184" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Free+fatty+acid+depletion+acutely+decreases+cardiac+work+and+efficiency+in+cardiomyopathic+heart+failure&amp;author=H+Tuunanen&amp;volume=114&amp;publication_year=2006&amp;pages=2130-2137&amp;pmid=17088453&amp;doi=10.1161/CIRCULATIONAHA.106.645184&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR52">52. <span class="element-citation">Angelidi AM, et al. Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity. <span><span class="ref-journal">Metabolism. </span>2023;<span class="ref-vol">138</span>:155346. doi: 10.1016/j.metabol.2022.155346.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36375643" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.metabol.2022.155346" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Metabolism&amp;title=Early+metabolomic,+lipid+and+lipoprotein+changes+in+response+to+medical+and+surgical+therapeutic+approaches+to+obesity&amp;author=AM+Angelidi&amp;volume=138&amp;publication_year=2023&amp;pages=155346&amp;pmid=36375643&amp;doi=10.1016/j.metabol.2022.155346&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR53">53. <span class="element-citation">de Freitas Germano J, et al. Proteomics of mouse heart ventricles reveals mitochondria and metabolism as major targets of a post-infarction short-acting glp1ra-therapy. <span><span class="ref-journal">Int. J. Mol. Sci. </span>2021;<span class="ref-vol">22</span>:8711. doi: 10.3390/ijms22168711.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8395861/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34445425" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fijms22168711" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Mol.+Sci.&amp;title=Proteomics+of+mouse+heart+ventricles+reveals+mitochondria+and+metabolism+as+major+targets+of+a+post-infarction+short-acting+glp1ra-therapy&amp;author=J+de+Freitas+Germano&amp;volume=22&amp;publication_year=2021&amp;pages=8711&amp;pmid=34445425&amp;doi=10.3390/ijms22168711&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR54">54. <span class="element-citation">Li DJ, et al. Brexpiprazole caused glycolipid metabolic disorder by inhibiting GLP1/GLP1R signaling in rats. <span><span class="ref-journal">Acta pharmacologica Sin. </span>2021;<span class="ref-vol">42</span>:1267–1279. doi: 10.1038/s41401-021-00680-x.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8285380/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33976388" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41401-021-00680-x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+pharmacologica+Sin.&amp;title=Brexpiprazole+caused+glycolipid+metabolic+disorder+by+inhibiting+GLP1/GLP1R+signaling+in+rats&amp;author=DJ+Li&amp;volume=42&amp;publication_year=2021&amp;pages=1267-1279&amp;doi=10.1038/s41401-021-00680-x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR55">55. <span class="element-citation">Packer M. Foetal recapitulation of nutrient surplus signalling by O-GlcNAcylation and the failing heart. <span><span class="ref-journal">Eur. J. heart Fail. </span>2023;<span class="ref-vol">25</span>:1199–1212. doi: 10.1002/ejhf.2972.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37434410" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fejhf.2972" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur.+J.+heart+Fail.&amp;title=Foetal+recapitulation+of+nutrient+surplus+signalling+by+O-GlcNAcylation+and+the+failing+heart&amp;author=M+Packer&amp;volume=25&amp;publication_year=2023&amp;pages=1199-1212&amp;pmid=37434410&amp;doi=10.1002/ejhf.2972&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR56">56. <span class="element-citation">Wang X, et al. ATF4 protects the heart from failure by antagonizing oxidative stress. <span><span class="ref-journal">Circulation Res. </span>2022;<span class="ref-vol">131</span>:91–105. doi: 10.1161/CIRCRESAHA.122.321050.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9351829/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35574856" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1161%2FCIRCRESAHA.122.321050" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation+Res.&amp;title=ATF4+protects+the+heart+from+failure+by+antagonizing+oxidative+stress&amp;author=X+Wang&amp;volume=131&amp;publication_year=2022&amp;pages=91-105&amp;pmid=35574856&amp;doi=10.1161/CIRCRESAHA.122.321050&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR57">57. <span class="element-citation">Rao X, et al. O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth. <span><span class="ref-journal">Nat. Commun. </span>2015;<span class="ref-vol">6</span>:8468. doi: 10.1038/ncomms9468.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4598839/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26399441" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fncomms9468" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Commun.&amp;title=O-GlcNAcylation+of+G6PD+promotes+the+pentose+phosphate+pathway+and+tumor+growth&amp;author=X+Rao&amp;volume=6&amp;publication_year=2015&amp;pages=8468&amp;pmid=26399441&amp;doi=10.1038/ncomms9468&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR58">58. <span class="element-citation">Ritterhoff J, et al. Metabolic remodeling promotes cardiac hypertrophy by directing glucose to aspartate biosynthesis. <span><span class="ref-journal">Circulation Res. </span>2020;<span class="ref-vol">126</span>:182–196. doi: 10.1161/CIRCRESAHA.119.315483.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8448129/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31709908" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1161%2FCIRCRESAHA.119.315483" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation+Res.&amp;title=Metabolic+remodeling+promotes+cardiac+hypertrophy+by+directing+glucose+to+aspartate+biosynthesis&amp;author=J+Ritterhoff&amp;volume=126&amp;publication_year=2020&amp;pages=182-196&amp;pmid=31709908&amp;doi=10.1161/CIRCRESAHA.119.315483&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR59">59. <span class="element-citation">Lehmann LH, et al. A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway. <span><span class="ref-journal">Nat. Med. </span>2018;<span class="ref-vol">24</span>:62–72. doi: 10.1038/nm.4452.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29227474" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnm.4452" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Med.&amp;title=A+proteolytic+fragment+of+histone+deacetylase+4+protects+the+heart+from+failure+by+regulating+the+hexosamine+biosynthetic+pathway&amp;author=LH+Lehmann&amp;volume=24&amp;publication_year=2018&amp;pages=62-72&amp;pmid=29227474&amp;doi=10.1038/nm.4452&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR60">60. <span class="element-citation">Ji JJ, et al. Kallistatin/Serpina3c inhibits cardiac fibrosis after myocardial infarction by regulating glycolysis via Nr4a1 activation. <span><span class="ref-journal">Biochim Biophys. Acta Mol. Basis Dis. </span>2022;<span class="ref-vol">1868</span>:166441. doi: 10.1016/j.bbadis.2022.166441.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35577178" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.bbadis.2022.166441" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys.+Acta+Mol.+Basis+Dis.&amp;title=Kallistatin/Serpina3c+inhibits+cardiac+fibrosis+after+myocardial+infarction+by+regulating+glycolysis+via+Nr4a1+activation&amp;author=JJ+Ji&amp;volume=1868&amp;publication_year=2022&amp;pages=166441&amp;pmid=35577178&amp;doi=10.1016/j.bbadis.2022.166441&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR61">61. <span class="element-citation">Herring JA, Elison WS, Tessem JS. Function of Nr4a orphan nuclear receptors in proliferation, apoptosis and fuel utilization across tissues. <span><span class="ref-journal">Cells. </span>2019;<span class="ref-vol">8</span>:1373. doi: 10.3390/cells8111373.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6912296/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31683815" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fcells8111373" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=Function+of+Nr4a+orphan+nuclear+receptors+in+proliferation,+apoptosis+and+fuel+utilization+across+tissues&amp;author=JA+Herring&amp;author=WS+Elison&amp;author=JS+Tessem&amp;volume=8&amp;publication_year=2019&amp;pages=1373&amp;pmid=31683815&amp;doi=10.3390/cells8111373&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR62">62. <span class="element-citation">Shrestha R, et al. Flavonoids kaempferol and quercetin are nuclear receptor 4A1 (NR4A1, Nur77) ligands and inhibit rhabdomyosarcoma cell and tumor growth. <span><span class="ref-journal">J. Exp. Clin. cancer Res.: CR. </span>2021;<span class="ref-vol">40</span>:392. doi: 10.1186/s13046-021-02199-9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8670039/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34906197" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2Fs13046-021-02199-9" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Exp.+Clin.+cancer+Res.:+CR&amp;title=Flavonoids+kaempferol+and+quercetin+are+nuclear+receptor+4A1+(NR4A1,+Nur77)+ligands+and+inhibit+rhabdomyosarcoma+cell+and+tumor+growth&amp;author=R+Shrestha&amp;volume=40&amp;publication_year=2021&amp;pages=392&amp;pmid=34906197&amp;doi=10.1186/s13046-021-02199-9&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR63">63. <span class="element-citation">Zhan Y, et al. Cytosporone B is an agonist for nuclear orphan receptor Nur77. <span><span class="ref-journal">Nat. Chem. Biol. </span>2008;<span class="ref-vol">4</span>:548–556. doi: 10.1038/nchembio.106.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18690216" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnchembio.106" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Chem.+Biol.&amp;title=Cytosporone+B+is+an+agonist+for+nuclear+orphan+receptor+Nur77&amp;author=Y+Zhan&amp;volume=4&amp;publication_year=2008&amp;pages=548-556&amp;pmid=18690216&amp;doi=10.1038/nchembio.106&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR64">64. <span class="element-citation">Zhan YY, et al. The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK. <span><span class="ref-journal">Nat. Chem. Biol. </span>2012;<span class="ref-vol">8</span>:897–904. doi: 10.1038/nchembio.1069.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22983157" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnchembio.1069" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Chem.+Biol.&amp;title=The+orphan+nuclear+receptor+Nur77+regulates+LKB1+localization+and+activates+AMPK&amp;author=YY+Zhan&amp;volume=8&amp;publication_year=2012&amp;pages=897-904&amp;pmid=22983157&amp;doi=10.1038/nchembio.1069&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR65">65. <span class="element-citation">Jiang NX, Zhao WJ, Shen HR, Du DF, Li XL. Hyperinsulinemia impairs decidualization via AKT-NR4A1 signaling: new insight into polycystic ovary syndrome (PCOS)-related infertility. <span><span class="ref-journal">J. ovarian Res. </span>2024;<span class="ref-vol">17</span>:31. doi: 10.1186/s13048-023-01334-8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10837998/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/38310251" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2Fs13048-023-01334-8" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+ovarian+Res.&amp;title=Hyperinsulinemia+impairs+decidualization+via+AKT-NR4A1+signaling:+new+insight+into+polycystic+ovary+syndrome+(PCOS)-related+infertility&amp;author=NX+Jiang&amp;author=WJ+Zhao&amp;author=HR+Shen&amp;author=DF+Du&amp;author=XL+Li&amp;volume=17&amp;publication_year=2024&amp;pages=31&amp;pmid=38310251&amp;doi=10.1186/s13048-023-01334-8&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR66">66. <span class="element-citation">Koenis DS, et al. Nuclear receptor nur77 limits the macrophage inflammatory response through transcriptional reprogramming of mitochondrial metabolism. <span><span class="ref-journal">Cell Rep. </span>2018;<span class="ref-vol">24</span>:2127–2140.e2127. doi: 10.1016/j.celrep.2018.07.065.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6113932/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30134173" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.celrep.2018.07.065" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Rep.&amp;title=Nuclear+receptor+nur77+limits+the+macrophage+inflammatory+response+through+transcriptional+reprogramming+of+mitochondrial+metabolism&amp;author=DS+Koenis&amp;volume=24&amp;publication_year=2018&amp;pages=2127-2140.e2127&amp;pmid=30134173&amp;doi=10.1016/j.celrep.2018.07.065&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR67">67. <span class="element-citation">Chen L, et al. Emodin promotes hepatic stellate cell senescence and alleviates liver fibrosis via a nuclear receptor (Nur77)-mediated epigenetic regulation of glutaminase 1. <span><span class="ref-journal">Br. J. Pharmacol. </span>2023;<span class="ref-vol">180</span>:2577–2598. doi: 10.1111/bph.16156.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37263753" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fbph.16156" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br.+J.+Pharmacol.&amp;title=Emodin+promotes+hepatic+stellate+cell+senescence+and+alleviates+liver+fibrosis+via+a+nuclear+receptor+(Nur77)-mediated+epigenetic+regulation+of+glutaminase+1&amp;author=L+Chen&amp;volume=180&amp;publication_year=2023&amp;pages=2577-2598&amp;pmid=37263753&amp;doi=10.1111/bph.16156&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR68">68. <span class="element-citation">Venu VKP, et al. Metformin prevents hyperglycemia-associated, oxidative stress-induced vascular endothelial dysfunction: essential role for the orphan nuclear receptor human nuclear receptor 4A1 (Nur77) <span><span class="ref-journal">Mol. Pharmacol. </span>2021;<span class="ref-vol">100</span>:428–455. doi: 10.1124/molpharm.120.000148.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34452975" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1124%2Fmolpharm.120.000148" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Pharmacol.&amp;title=Metformin+prevents+hyperglycemia-associated,+oxidative+stress-induced+vascular+endothelial+dysfunction:+essential+role+for+the+orphan+nuclear+receptor+human+nuclear+receptor+4A1+(Nur77)&amp;author=VKP+Venu&amp;volume=100&amp;publication_year=2021&amp;pages=428-455&amp;pmid=34452975&amp;doi=10.1124/molpharm.120.000148&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR69">69. <span class="element-citation">Li P, et al. NR4A1 contributes to high-fat associated endothelial dysfunction by promoting CaMKII-Parkin-mitophagy pathways. <span><span class="ref-journal">Cell stress chaperones. </span>2018;<span class="ref-vol">23</span>:749–761. doi: 10.1007/s12192-018-0886-1.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6045535/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29470798" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs12192-018-0886-1" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+stress+chaperones&amp;title=NR4A1+contributes+to+high-fat+associated+endothelial+dysfunction+by+promoting+CaMKII-Parkin-mitophagy+pathways&amp;author=P+Li&amp;volume=23&amp;publication_year=2018&amp;pages=749-761&amp;pmid=29470798&amp;doi=10.1007/s12192-018-0886-1&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR70">70. <span class="element-citation">Kanemaru K, et al. Spatially resolved multiomics of human cardiac niches. <span><span class="ref-journal">Nature. </span>2023;<span class="ref-vol">619</span>:801–810. doi: 10.1038/s41586-023-06311-1.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10371870/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37438528" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41586-023-06311-1" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Spatially+resolved+multiomics+of+human+cardiac+niches&amp;author=K+Kanemaru&amp;volume=619&amp;publication_year=2023&amp;pages=801-810&amp;pmid=37438528&amp;doi=10.1038/s41586-023-06311-1&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR71">71. <span class="element-citation">Basalay MV, et al. Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning. <span><span class="ref-journal">Cardiovascular Res. </span>2016;<span class="ref-vol">112</span>:669–676. doi: 10.1093/cvr/cvw216.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5157137/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27702763" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Fcvr%2Fcvw216" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular+Res.&amp;title=Glucagon-like+peptide-1+(GLP-1)+mediates+cardioprotection+by+remote+ischaemic+conditioning&amp;author=MV+Basalay&amp;volume=112&amp;publication_year=2016&amp;pages=669-676&amp;doi=10.1093/cvr/cvw216&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR72">72. <span class="element-citation">Saw EL, et al. Activation of the cardiac non-neuronal cholinergic system prevents the development of diabetes-associated cardiovascular complications. <span><span class="ref-journal">Cardiovascular Diabetol. </span>2021;<span class="ref-vol">20</span>:50. doi: 10.1186/s12933-021-01231-8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7898760/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33618724" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2Fs12933-021-01231-8" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular+Diabetol.&amp;title=Activation+of+the+cardiac+non-neuronal+cholinergic+system+prevents+the+development+of+diabetes-associated+cardiovascular+complications&amp;author=EL+Saw&amp;volume=20&amp;publication_year=2021&amp;pages=50&amp;doi=10.1186/s12933-021-01231-8&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR73">73. <span class="element-citation">Shrestha N, et al. Lipopolysaccharide-induced sepsis impairs M2R-GIRK signaling in the mouse sinoatrial node. <span><span class="ref-journal">Proc. Natl Acad. Sci. USA. </span>2023;<span class="ref-vol">120</span>:e2210152120. doi: 10.1073/pnas.2210152120.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10334783/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37406102" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1073%2Fpnas.2210152120" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl+Acad.+Sci.+USA&amp;title=Lipopolysaccharide-induced+sepsis+impairs+M2R-GIRK+signaling+in+the+mouse+sinoatrial+node&amp;author=N+Shrestha&amp;volume=120&amp;publication_year=2023&amp;pages=e2210152120&amp;pmid=37406102&amp;doi=10.1073/pnas.2210152120&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR74">74. <span class="element-citation">Schunke KJ, et al. Outcomes of hypothalamic oxytocin neuron-driven cardioprotection after acute myocardial infarction. <span><span class="ref-journal">Basic Res. Cardiol. </span>2023;<span class="ref-vol">118</span>:43. doi: 10.1007/s00395-023-01013-1.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10558415/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37801130" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00395-023-01013-1" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Basic+Res.+Cardiol.&amp;title=Outcomes+of+hypothalamic+oxytocin+neuron-driven+cardioprotection+after+acute+myocardial+infarction&amp;author=KJ+Schunke&amp;volume=118&amp;publication_year=2023&amp;pages=43&amp;pmid=37801130&amp;doi=10.1007/s00395-023-01013-1&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR75">75. <span class="mixed-citation">Wong, C. K., et al. Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation.<em>Cell Metab</em>. <strong>36</strong>, 130&#x02013;143.e5 (2023). [<a href="https://pubmed.ncbi.nlm.nih.gov/38113888" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR76">76. <span class="element-citation">Patten RD, Hall-Porter MR. Small animal models of heart failure: development of novel therapies, past and present. <span><span class="ref-journal">Circulation. Heart Fail. </span>2009;<span class="ref-vol">2</span>:138–144. doi: 10.1161/CIRCHEARTFAILURE.108.839761.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19808329" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1161%2FCIRCHEARTFAILURE.108.839761" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation.+Heart+Fail.&amp;title=Small+animal+models+of+heart+failure:+development+of+novel+therapies,+past+and+present&amp;author=RD+Patten&amp;author=MR+Hall-Porter&amp;volume=2&amp;publication_year=2009&amp;pages=138-144&amp;doi=10.1161/CIRCHEARTFAILURE.108.839761&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR77">77. <span class="element-citation">Xie S, et al. Diminished arachidonate 5-lipoxygenase perturbs phase separation and transcriptional response of Runx2 to reverse pathological ventricular remodeling. <span><span class="ref-journal">EBioMedicine. </span>2022;<span class="ref-vol">86</span>:104359. doi: 10.1016/j.ebiom.2022.104359.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9672960/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36395739" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.ebiom.2022.104359" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=EBioMedicine&amp;title=Diminished+arachidonate+5-lipoxygenase+perturbs+phase+separation+and+transcriptional+response+of+Runx2+to+reverse+pathological+ventricular+remodeling&amp;author=S+Xie&amp;volume=86&amp;publication_year=2022&amp;pages=104359&amp;pmid=36395739&amp;doi=10.1016/j.ebiom.2022.104359&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR78">78. <span class="element-citation">Enebo LB, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2&#x000b7;4 mg for weight management: a randomised, controlled, phase 1b trial. <span><span class="ref-journal">Lancet. </span>2021;<span class="ref-vol">397</span>:1736–1748. doi: 10.1016/S0140-6736(21)00845-X.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33894838" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0140-6736(21)00845-X" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Safety,+tolerability,+pharmacokinetics,+and+pharmacodynamics+of+concomitant+administration+of+multiple+doses+of+cagrilintide+with+semaglutide+2&#x000b7;4+mg+for+weight+management:+a+randomised,+controlled,+phase+1b+trial&amp;author=LB+Enebo&amp;volume=397&amp;publication_year=2021&amp;pages=1736-1748&amp;pmid=33894838&amp;doi=10.1016/S0140-6736(21)00845-X&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR79">79. <span class="element-citation">Rakipovski G, et al. The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE(-/-) and LDLr(-/-) mice by a mechanism that includes inflammatory pathways. <span><span class="ref-journal">JACC Basic Transl. Sci. </span>2018;<span class="ref-vol">3</span>:844–857. doi: 10.1016/j.jacbts.2018.09.004.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6314963/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30623143" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jacbts.2018.09.004" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JACC+Basic+Transl.+Sci.&amp;title=The+GLP-1+analogs+liraglutide+and+semaglutide+reduce+atherosclerosis+in+ApoE(-/-)+and+LDLr(-/-)+mice+by+a+mechanism+that+includes+inflammatory+pathways&amp;author=G+Rakipovski&amp;volume=3&amp;publication_year=2018&amp;pages=844-857&amp;pmid=30623143&amp;doi=10.1016/j.jacbts.2018.09.004&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR80">80. <span class="element-citation">Xie SY, et al. USP28 serves as a key suppressor of mitochondrial morphofunctional defects and cardiac dysfunction in the diabetic heart. <span><span class="ref-journal">Circulation. </span>2024;<span class="ref-vol">149</span>:684–706. doi: 10.1161/CIRCULATIONAHA.123.065603.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37994595" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1161%2FCIRCULATIONAHA.123.065603" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=USP28+serves+as+a+key+suppressor+of+mitochondrial+morphofunctional+defects+and+cardiac+dysfunction+in+the+diabetic+heart&amp;author=SY+Xie&amp;volume=149&amp;publication_year=2024&amp;pages=684-706&amp;pmid=37994595&amp;doi=10.1161/CIRCULATIONAHA.123.065603&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR81">81. <span class="element-citation">Zhang X, et al. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. <span><span class="ref-journal">Cell death Differ. </span>2020;<span class="ref-vol">27</span>:540–555. doi: 10.1038/s41418-019-0372-z.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7206111/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31209361" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41418-019-0372-z" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+death+Differ.&amp;title=FNDC5+alleviates+oxidative+stress+and+cardiomyocyte+apoptosis+in+doxorubicin-induced+cardiotoxicity+via+activating+AKT&amp;author=X+Zhang&amp;volume=27&amp;publication_year=2020&amp;pages=540-555&amp;pmid=31209361&amp;doi=10.1038/s41418-019-0372-z&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR82">82. <span class="element-citation">Ma ZG, et al. Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice. <span><span class="ref-journal">Theranostics. </span>2020;<span class="ref-vol">10</span>:11013–11025. doi: 10.7150/thno.47516.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7532690/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33042267" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.7150%2Fthno.47516" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=Toll-like+receptor+5+deficiency+diminishes+doxorubicin-induced+acute+cardiotoxicity+in+mice&amp;author=ZG+Ma&amp;volume=10&amp;publication_year=2020&amp;pages=11013-11025&amp;pmid=33042267&amp;doi=10.7150/thno.47516&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR83">83. <span class="element-citation">Li C, et al. PCSK6 attenuates cardiac dysfunction in doxorubicin-induced cardiotoxicity by regulating autophagy. <span><span class="ref-journal">Free Radic. Biol. Med. </span>2023;<span class="ref-vol">203</span>:114–128. doi: 10.1016/j.freeradbiomed.2023.04.005.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37061139" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.freeradbiomed.2023.04.005" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Free+Radic.+Biol.+Med&amp;title=PCSK6+attenuates+cardiac+dysfunction+in+doxorubicin-induced+cardiotoxicity+by+regulating+autophagy&amp;author=C+Li&amp;volume=203&amp;publication_year=2023&amp;pages=114-128&amp;pmid=37061139&amp;doi=10.1016/j.freeradbiomed.2023.04.005&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR84">84. <span class="element-citation">DeMaere MZ, Darling AE. qc3C: Reference-free quality control for Hi-C sequencing data. <span><span class="ref-journal">PLoS Comput Biol. </span>2021;<span class="ref-vol">17</span>:e1008839. doi: 10.1371/journal.pcbi.1008839.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8530316/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34634030" ref="reftype=pubmed&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1371%2Fjournal.pcbi.1008839" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Comput+Biol.&amp;title=qc3C:+Reference-free+quality+control+for+Hi-C+sequencing+data&amp;author=MZ+DeMaere&amp;author=AE+Darling&amp;volume=17&amp;publication_year=2021&amp;pages=e1008839&amp;pmid=34634030&amp;doi=10.1371/journal.pcbi.1008839&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11150406&amp;issue-id=452197&amp;journal-id=2873&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Nature Communications</span> are provided here courtesy of <strong>Nature Publishing Group</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC11150406/pdf/41467_2024_Article_48970.pdf" class="int-view">PDF (6.5M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/11150406/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/11150406/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="11150406" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11150406%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="M4TK2vqjEv1YS8OAu1kItg679pwNlI5Q08w5RoG45ncK4YNu9nMLb2SYT43pWEDV">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11150406%2F&amp;text=Semaglutide%20ameliorates%20cardiac%20remodeling%20in%20male%20mice%20by%20optimizing%20energy%20substrate%20utilization%20through%20the%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11150406%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11150406/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC11150406/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/38834564/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC11150406/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/38834564/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC11150406/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/11150406/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC11150406/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
